<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1473210</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2024.1473210</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Transcriptional regulation in the absence of inositol trisphosphate receptor calcium signaling</article-title>
<alt-title alt-title-type="left-running-head">Young et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2024.1473210">10.3389/fcell.2024.1473210</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Young</surname>
<given-names>Michael</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2815864/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Booth</surname>
<given-names>David M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1858351/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Smith</surname>
<given-names>David</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2850778/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tigano</surname>
<given-names>Marco</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1436648/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hajn&#x3cc;czky</surname>
<given-names>Gy&#x4e7;rgy</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/51903/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Joseph</surname>
<given-names>Suresh K.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2798508/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>MitoCare Center</institution>, <institution>Department of Pathology and Genomic Medicine</institution>, <institution>Thomas Jefferson University</institution>, <addr-line>Philadelphia</addr-line>, <addr-line>PA</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Center for Single Cell Biology</institution>, <institution>Children&#x2019;s Hospital of Philadelphia</institution>, <addr-line>Philadelphia</addr-line>, <addr-line>PA</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/70276/overview">Nan-Shan Chang</ext-link>, China Medical University, Taiwan</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1242840/overview">Maud Frieden</ext-link>, University of Geneva, Switzerland</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2813601/overview">Yandong Zhou</ext-link>, Penn State College of Medicine, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Suresh K. Joseph, <email>suresh.joseph@jefferson.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>06</day>
<month>12</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>1473210</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>07</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>11</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Young, Booth, Smith, Tigano, Hajn&#x3cc;czky and Joseph.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Young, Booth, Smith, Tigano, Hajn&#x3cc;czky and Joseph</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>The activation of IP<sub>3</sub> receptor (IP<sub>3</sub>R) Ca<sup>2&#x2b;</sup> channels generates agonist-mediated Ca<sup>2&#x2b;</sup> signals that are critical for the regulation of a wide range of biological processes. It is therefore surprising that CRISPR induced loss of all three IP<sub>3</sub>R isoforms (TKO) in HEK293 and HeLa cell lines yields cells that can survive, grow and divide, albeit more slowly than wild-type cells. In an effort to understand the adaptive mechanisms involved, we have examined the activity of key Ca<sup>2&#x2b;</sup> dependent transcription factors (NFAT, CREB and AP-1) and signaling pathways using luciferase-reporter assays, phosphoprotein immunoblots and whole genome transcriptomic studies. In addition, the diacylglycerol arm of the signaling pathway was investigated with protein kinase C (PKC) inhibitors and siRNA knockdown. The data showed that agonist-mediated NFAT activation was lost but CREB activation was maintained in IP<sub>3</sub>R TKO cells. Under base-line conditions transcriptome analysis indicated the differential expression of 828 and 311 genes in IP<sub>3</sub>R TKO HEK293 or HeLa cells, respectively, with only 18 genes being in common. Three main adaptations in TKO cells were identified in this study: 1) increased basal activity of NFAT, CREB and AP-1; 2) an increased reliance on Ca<sup>2&#x2b;</sup>- insensitive PKC isoforms; and 3) increased production of reactive oxygen species and upregulation of antioxidant defense enzymes. We suggest that whereas wild-type cells rely on a Ca<sup>2&#x2b;</sup> and DAG signal to respond to stimuli, the TKO cells utilize the adaptations to allow key signaling pathways (e.g., PKC, Ras/MAPK, CREB) to transition to the activated state using a DAG signal alone.</p>
</abstract>
<kwd-group>
<kwd>calcium signaling</kwd>
<kwd>IP<sub>3</sub> receptor</kwd>
<kwd>Ca<sup>2&#x2b;</sup> dependent transcription</kwd>
<kwd>NFAT</kwd>
<kwd>CREB</kwd>
<kwd>calcineurin</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Signaling</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>1 Introduction</title>
<p>Calcium is viewed as a vital signaling molecule that regulates many important physiological processes including growth, cell division, motility, gene expression and metabolism (<xref ref-type="bibr" rid="B9">Berridge et al., 2003</xref>). Agonist-mediated Ca<sup>2&#x2b;</sup> signals are evoked as a result of the formation of inositol 1,4,5-trisphosphate (IP<sub>3</sub>), which opens IP<sub>3</sub>R channels in endoplasmic reticulum membranes, and diacylglycerol which activates a family of Ca<sup>2&#x2b;</sup> -dependent or independent protein kinase C (PKC) isoforms. Three IP<sub>3</sub>R isoforms are expressed in cells and several labs have successfully genetically deleted all three isoforms to generate IP<sub>3</sub>R triple knockout cells (TKO). This includes chicken DT40 cells (<xref ref-type="bibr" rid="B73">Sugawara et al., 1997</xref>), mouse&#xa0;T and B lymphocytes (<xref ref-type="bibr" rid="B56">Ouyang et al., 2014</xref>; <xref ref-type="bibr" rid="B75">Tang et al., 2017</xref>), HEK293 cells (<xref ref-type="bibr" rid="B4">Alzayady et al., 2016</xref>; <xref ref-type="bibr" rid="B87">Yue et al., 2020</xref>), HeLa cells (<xref ref-type="bibr" rid="B5">Ando et al., 2018</xref>), mouse embryonic stem cells (<xref ref-type="bibr" rid="B81">Wang et al., 2017</xref>) and human induced pluripotent stem cells (<xref ref-type="bibr" rid="B65">Ronkko et al., 2023</xref>). All these model systems completely lack agonist-mediated Ca<sup>2&#x2b;</sup> signals. In view of the proposed central role of Ca<sup>2&#x2b;</sup> signaling, it is surprising that these cells display a somewhat mild phenotype and continue to grow and divide, in some cases more slowly (<xref ref-type="bibr" rid="B82">Wen et al., 2015</xref>; <xref ref-type="bibr" rid="B39">Lagos-Cabre et al., 2020</xref>; <xref ref-type="bibr" rid="B87">Yue et al., 2020</xref>; <xref ref-type="bibr" rid="B86">Young et al., 2022</xref>), and in some cases at rates indistinguishable from wild type cells (<xref ref-type="bibr" rid="B81">Wang et al., 2017</xref>; <xref ref-type="bibr" rid="B65">Ronkko et al., 2023</xref>). This suggests that TKO cells have adapted to the chronic loss of Ca<sup>2&#x2b;</sup> signaling. However, the compensatory mechanisms that enable these cells to maintain homeostasis and reconfigure their transcriptional landscape in the absence of Ca<sup>2&#x2b;</sup> have not been investigated.</p>
<p>Many transcriptional regulators are modulated by Ca<sup>2&#x2b;</sup> signals. Early studies showed that Ca<sup>2&#x2b;</sup> signals rapidly induced expression of the proto-oncogene c-fos upon stimulation of receptors for acetylcholine in PC12 cells (<xref ref-type="bibr" rid="B22">Greenberg et al., 1986</xref>) or growth factors in quiescent fibroblasts (<xref ref-type="bibr" rid="B21">Greenberg and Ziff, 1984</xref>). Both NFAT and CREB are also activated by increased Ca<sup>2&#x2b;</sup> signaling (<xref ref-type="bibr" rid="B83">West et al., 2001</xref>; <xref ref-type="bibr" rid="B76">Thiel et al., 2021</xref>; <xref ref-type="bibr" rid="B49">Masaki and Shimada, 2022</xref>). AP-1, which are transcription factors composed of dimers of fos and jun family members, are also regulated by Ca<sup>2&#x2b;</sup> (<xref ref-type="bibr" rid="B64">Roche and Prentki, 1994</xref>; <xref ref-type="bibr" rid="B84">Yeh and Parekh, 2018</xref>). Multiple signaling pathways are involved in the activation of Ca<sup>2&#x2b;</sup>-sensitive transcription factors including protein kinase C (PKC), RAS/MAPK and Jnk. In the present study, we have used luciferase reporter assays to measure the activity of transcription factors and biochemical assays to monitor signaling pathways. We used TKO cells from two different human cancer cell lines (HEK293 and HeLa) to identify the Ca<sup>2&#x2b;</sup>-dependent transcriptional pathways that have been inactivated or that continue to function. We have also examined the global expression of genes by RNAseq in both models. Although there are some differences in the behavior of the 2&#xa0;cell lines, our main findings are that TKO cells show an increased baseline activity of NFAT, CREB and AP-1, an increased reliance on Ca<sup>2&#x2b;</sup>-insensitive PKC isoforms, and a hitherto unrecognized alteration in the handling of ROS and redox poise. All of these changes may contribute to the ability of these cells to grow and divide in the absence of Ca<sup>2&#x2b;</sup> signaling.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and Methods</title>
<sec id="s2-1">
<title>2.1 Cell lines and culture</title>
<p>All cells were cultured at 37&#xb0;C and 5% CO<sub>2</sub> in Dulbecco&#x2019;s modified Eagle&#x2019;s medium (DMEM) supplemented with 5% fetal bovine serum, 1% penicillin/streptomycin and 0.25&#xa0;&#x3bc;g/mL amphotericin B. HEK293 WT, IP<sub>3</sub>R TKO and IP<sub>3</sub>R1 rescue cells were the kind gift of Dr. David Yule (<xref ref-type="bibr" rid="B4">Alzayady et al., 2016</xref>; <xref ref-type="bibr" rid="B7">Arige et al., 2022</xref>). WT and and IP<sub>3</sub>R TKO HeLa cells were a kind gift of Katsuhiko Mikoshiba (<xref ref-type="bibr" rid="B5">Ando et al., 2018</xref>). All experiments were conducted with a normal level of extracellular Ca<sup>2&#x2b;</sup> (2.5&#xa0;mM).</p>
</sec>
<sec id="s2-2">
<title>2.2 Luciferase reporter assays</title>
<p>2 &#xd7; 10<sup>5</sup> cells were plated in 12-well dishes and grown to 70%&#x2013;80% confluency. The reporter constructs used were as follows: pGL3-NFAT luciferase, Addgene &#x23;17870; pGL3-3xAP1, Addgene &#x23;40342; pGL4.29-CRE, Promega &#x23;E8471; pGL4.32-NFkb-RE, Promega &#x23;E8491. Cells were transfected with 1ug DNA/well of reporter gene-luciferase and 0.2&#xa0;ug/well of <italic>Renilla</italic> luciferase (a kind gift of Dr. Makarand Risbud) using Lipofectamine 3000 (ThermoFisher Scientific). After 24&#xa0;h, cells were subjected to various treatments for 4&#xa0;h and then lysed with 1X Firefly Luciferase assay buffer (Biotium Corporation). A Luciferase Assay Kit 2.0 (Biotium Corporation) was used to measure firefly and <italic>Renilla</italic> luciferase activity on a Synergy Neo2 (Biotek) plate reader.</p>
</sec>
<sec id="s2-3">
<title>2.3 SDS-PAGE/Western blotting</title>
<p>To prepare lysates, cells incubated in DMEM were washed in PBS and lysed in a 0.25&#xa0;mL of WB buffer containing 1% Triton X-100, 50&#xa0;mM Tris/HCl pH 7.8, 150&#xa0;mM NaCl, 2&#xa0;mM sodium orthovanadate, 10&#xa0;mM sodium pyrophosphate, 20&#xa0;mM NaF, and a 1x dilution of a complete protease inhibitor mixture (Roche Diagnostics). The lysates were centrifuged at 12,000 &#xd7;g for 10&#xa0;min. The supernatants were denatured in SDS sample buffer. Lysates were boiled at 100&#xb0;C for 5&#xa0;min, then stored at &#x2212;20&#xb0;C until use. Unless otherwise noted, 40&#xa0;&#xb5;g of protein were run at 100V for 90min on 10% polyacrylamide gels and transferred at 100V for 60&#xa0;min onto nitrocellulose membranes. Polyvinylidene difluoride membranes were used in the specific case of LC3 immunoblotting. Membranes were blocked in TBST supplemented with 5% BSA for 1&#xa0;h at room temperature. Following 3 &#xd7; 15&#xa0;min washes in TBST, the primary Ab was added for 16&#xa0;h at 4&#xb0;C. All Abs were used at a dilution of 1:1000 and were obtained from Cell Signaling. Membranes were developed using ECL reagent (ThermoFisher). When necessary membranes were stripped using a buffer containing SDS (2% w/v), Tris (62.5&#xa0;mM; pH6.8) and &#x3b2;-mercaptoethanol (100&#xa0;mM).</p>
</sec>
<sec id="s2-4">
<title>2.4 PKC&#x3b4; knockdown</title>
<p>2 &#xd7; 10<sup>5</sup> cells were plated in 60&#xa0;mm dishes, incubated at 37&#xb0;C, and grown to 70%&#x2013;80% confluency. Cells were transfected with either PKC&#x3b4; siRNA, non-targeted negative control siRNA, or Cy3 fluorescent positive control siRNA (OriGene Technologies Inc., Rockville, MD) using a Lipofectamine RNAiMAX kit (Thermo Fisher Scientific) then incubated at 37&#xb0;C for 48&#xa0;h.</p>
</sec>
<sec id="s2-5">
<title>2.5 RNAseq analysis</title>
<p>RNA was isolated using Direct-zol RNA Miniprep kit (Zymo Research, cat no. R2052) according to manufacturer&#x2019;s instructions and yielded samples with RIN values &#x3e; 7. Poly-A RNA sequencing library was prepared following Illumina&#x2019;s Tru-Seq-standard-mRNA sample preparation protocol. Poly(A) tail-containing mRNAs were purified using oligo-(dT) magnetic beads with two rounds of purification. After purification, poly(A) RNA was fragmented using divalent cation buffer in elevated temperature. Paired-ended sequencing was performed on Illumina&#x2019;s NovaSeq 6000 sequencing system. Reads were processed to remove adapter contamination, verified for sequence quality, and then assembled and mapped to the human genome. All library construction, sequencing and data processing was performed by LC Sciences, Houston, TX. The differentially expressed mRNAs were selected with log2 (fold change) &#x3e; 1 or log2 (fold change) &#x3c;-1 and with statistical significance (adjusted <italic>p</italic>-value &#x3c;0.05) by R package edgeR (<xref ref-type="bibr" rid="B63">Robinson et al., 2010</xref>).</p>
</sec>
<sec id="s2-6">
<title>2.6 Analysis of transcriptomic data</title>
<p>The volcano plots were drawn using the &#x2018;Volcano plots&#x2019; feature in the toolbox of the Galaxy web site (<ext-link ext-link-type="uri" xlink:href="https://usegalaxy.eu/">https://usegalaxy.eu/</ext-link>). Visualization of pathway enrichment of genes using the KEGG compendium of pathways was supplied by LC Sciences. Manual curation of differentially expressed genes (DEG) was done with the following data sets: calcium signaling (<xref ref-type="bibr" rid="B26">Hortenhuber et al., 2017</xref>)(<ext-link ext-link-type="uri" xlink:href="https://www.uhlenlab.org/cagedb/">https://www.uhlenlab.org/cagedb/</ext-link>), transcription factors (<xref ref-type="bibr" rid="B40">Lambert et al., 2018</xref>)(<ext-link ext-link-type="uri" xlink:href="http://humantfs.ccbr.utoronto.ca/allTFs.php">http://humantfs.ccbr.utoronto.ca/allTFs.php</ext-link>) and MitoCarta3 (<xref ref-type="bibr" rid="B61">Rath et al., 2021</xref>) (<ext-link ext-link-type="uri" xlink:href="https://personal.broadinstitute.org/scalvo/MitoCarta3.0/human.mitocarta3.0.html">https://personal.broadinstitute.org/scalvo/MitoCarta3.0/human.mitocarta3.0.html</ext-link>). Data sets of target genes for the transcription factor NFAT, CREB, AP-1 and NF-Kb were downloaded from the Harmonizome web site (<ext-link ext-link-type="uri" xlink:href="https://maayanlab.cloud/Harmonizome/).Gene">https://maayanlab.cloud/Harmonizome/).Gene</ext-link> Set Enrichment Analysis (GSEA) (<xref ref-type="bibr" rid="B72">Subramanian et al., 2005</xref>) was performed by GSEA software (v 4.1.0) using the Hallmark gene set documented in the MSigDB-C5 (v 7.3).</p>
</sec>
<sec id="s2-7">
<title>2.7 RT-qPCR</title>
<p>Cells were seeded at 5 &#xd7; 10<sup>5</sup> cell/well on a six-well plate and grown overnight at 37&#xb0;C. After treatment, total RNA was purified using a Direct-zol RNA Microprep kit (Zymo Research, cat no. R2052) according to manufacturer&#x2019;s instructions. Genomic DNA was eliminated by on-column digestion with DNaseI. RNA quality and quantity were measured using a NanoDrop. A total of 200&#xa0;ng RNA was reverse transcribed using 1&#xa0;&#xb5;L reverse transciptase (200U/mL, APEXbio, cat. no. K1071). qPCR reactions were performed in triplicate using HotStart 2X SYBR qPCR Master Mix, APEXbio, cat. no. K1070) according to the manufacturer&#x2019;s instructions on a QuantStudio5 (Applied Biosystems). Relative gene expression was normalized using either GAPDH or Actin as a housekeeping gene. The sequences of the primers used are given below:</p>
<table-wrap id="udT1" position="float">
<table>
<thead valign="top">
<tr>
<th align="left">Name</th>
<th align="left">Sequence (5&#x2032;-&#x3e;3&#x2032;)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">COX2-F</td>
<td align="left">CTG&#x200b;GCG&#x200b;CTC&#x200b;AGC&#x200b;CAT&#x200b;ACA&#x200b;G</td>
</tr>
<tr>
<td align="left">COX2-R</td>
<td align="left">CGC&#x200b;ACT&#x200b;TAT&#x200b;ACT&#x200b;GGT&#x200b;CAA&#x200b;ATC&#x200b;CC</td>
</tr>
<tr>
<td align="left">IRS2-F</td>
<td align="left">CAT&#x200b;TGA&#x200b;CTT&#x200b;CTT&#x200b;GTC&#x200b;CCA&#x200b;CCA&#x200b;C</td>
</tr>
<tr>
<td align="left">IRS2-R</td>
<td align="left">TGA&#x200b;AAC&#x200b;AGT&#x200b;GCT&#x200b;GAG&#x200b;CGT&#x200b;CTT&#x200b;C</td>
</tr>
<tr>
<td align="left">ETS1-F</td>
<td align="left">CAA&#x200b;GCC&#x200b;GAC&#x200b;TCT&#x200b;CAC&#x200b;CAT&#x200b;CA</td>
</tr>
<tr>
<td align="left">ETS1-R</td>
<td align="left">TGC&#x200b;ACA&#x200b;TTC&#x200b;CAT&#x200b;ATC&#x200b;CGG&#x200b;GG</td>
</tr>
<tr>
<td align="left">GAPDH-F</td>
<td align="left">TTG&#x200b;GCT&#x200b;ACA&#x200b;GCA&#x200b;ACA&#x200b;GGG&#x200b;TG</td>
</tr>
<tr>
<td align="left">GAPDH-R</td>
<td align="left">GGG&#x200b;GAG&#x200b;ATT&#x200b;CAG&#x200b;TGT&#x200b;GGT&#x200b;GG</td>
</tr>
<tr>
<td align="left">ACTB-F</td>
<td align="left">TCA&#x200b;CCC&#x200b;ACA&#x200b;CTG&#x200b;TGC&#x200b;CCA&#x200b;TCT&#x200b;ACG&#x200b;A</td>
</tr>
<tr>
<td align="left">ACTB-R</td>
<td align="left">CAG&#x200b;CGG&#x200b;AAC&#x200b;CGC&#x200b;TCA&#x200b;TTG&#x200b;CCA&#x200b;ATG&#x200b;G</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-8">
<title>2.8 ROS and redox measurements</title>
<p>Extracellular H<sub>2</sub>O<sub>2</sub> was measured using Amplex Red reagent (ThermoFisher; A12222). 5 &#xd7; 10<sup>5</sup> cells/well were seeded on black, clear bottom 96-well plates and grown in DMEM overnight. Medium was aspirated from all wells and replaced with 100&#xa0;&#xb5;L Amplex red assay buffer (HBSS, 10&#xa0;&#xb5;M Amplex Red, 0.4U/mL horseradish peroxidase). Fluorescence was measured every 5&#xa0;min for 1&#xa0;h using a Synergy Neo2 plate reader (Biotek Instruments) set at Ex 535&#xa0;nm and Em 590&#xa0;nm. After 1&#xa0;h, wells were aspirated, cells were lysed using 50&#xa0;&#xb5;L WB buffer and assayed for protein. Absolute values were estimated from a H<sub>2</sub>O<sub>2</sub> standard curve. Mitochondrial superoxide (O<sub>2</sub>
<sup>&#x2022;&#x2500;</sup>) was measured using a MitoSOX Red mitochondrial superoxide indicator (ThermoFisher; M36005). 5 &#xd7; 10<sup>5</sup> cells/well were seeded on black, clear bottom 96-well plates and grown in DMEM overnight. Medium was aspirated from all wells and replaced with 150&#xa0;&#xb5;L MitoSOX assay buffer (HBSS, 1&#xa0;&#xb5;M MitoSOX Red reagent, 5&#xa0;mM glucose, 1&#xa0;mM sodium pyruvate). Fluorescence was measured immediately and every 20&#xa0;min for 1&#xa0;h using a Synergy Neo2 plate reader (Biotek Instruments) set at Ex 510&#xa0;nm and Em 595&#xa0;nm. After 1h, wells were aspirated, cells were lysed using 50&#xa0;&#xb5;L WB buffer and assayed for protein. Intracellular H<sub>2</sub>O<sub>2</sub> was assessed using cells transiently transfected with cytosol-targeted pCS2&#x2b;HyPer7-NES (Addgene &#x23;136467). Fluorescence ratios Ex490/Ex405&#xa0;nm and Em 535 were obtained every 30&#xa0;s for 30&#xa0;min using the Synergy Neo2 plate reader. At the end of the experiment, sequential additions of dithiothreitol (DTT) were made to establish the Ex490/405&#xa0;nm minimum value representing fully reduced probe. Subsequently, sequential H<sub>2</sub>O<sub>2</sub> (200&#xa0;&#xb5;M) washes were performed until a stable Ex490/Ex405&#xa0;nm maximum ratio was achieved representing a fully oxidized probe. Results are presented as (R-R<sub>DTT</sub>)/(R<sub>H2O2</sub>-R<sub>DTT</sub>).Glutathione peroxidase was assayed with 1ug cell lysate in 96 clear well plates using an assay buffer containing 6&#xa0;mM GSH, 1.25&#xa0;mM NADPH and 500U glutathione reductase. After mixing, 100&#xa0;&#xb5;L 7&#xa0;mM H<sub>2</sub>O<sub>2</sub> was added and the absorbance of NADPH read at 340&#xa0;nm using a Synergy Neo2 plate reader every 10&#xa0;s for 5&#xa0;min. Rates of NADPH oxidation/mg protein were calculated from linear regions of the graphs.</p>
</sec>
<sec id="s2-9">
<title>2.9 Live cell imaging</title>
<p>Epifluorescence imaging of GSSG:GSH was carried in cells transiently transfected with cytosol and mitochondrial matrix-targeted Grx1roGFP2 (PMC8455442) Lipofectamine 3000 (ThermoFisher L300000) according to manufacturer&#x2019;s instructions. 24&#x2013;36&#xa0;h post transfection, cells were pre-incubated in HBSS supplemented with 2% BSA. For imaging, cells were washed and transferred to a similar solution containing 0.25% BSA. Imaging was carried out using a back-illuminated electron multiplying charge-coupled device (EMCCD) camera (EvolveEM 512 &#xd7; 512 pixel. Photometrics), mounted to an Olympus IX70 inverted microscope equipped with a Sutter DG4 light source. Fluorescence excitation was achieved with a custom dichroic derived from Chroma &#x23;59022 modified to enhance short wavelength excitation and bandpass filters specific to fluorophores. Grx1roGFP2 was imaged with dual excitation of 402/15 &#x26; 485/15&#xa0;nm. Analysis was carried out using the FIJI variant of ImageJ (NIH, version 1.52). Images were subject to background subtraction and registration (MultiStackreg plugin, registration matrices applied equally to all wavelengths). GSSG:GSH was calculated using formula (R-Rmin)/(Rmax-Rmin) where Rmin &#x26; Rmax values were obtained via complete reduction (DTT) and oxidation (H<sub>2</sub>O<sub>2</sub>) of Grx1roGFP at the end of each experiment. Excitation frequencies in Grx1roGFP2 are reversed, short wavelength/long wavelength to ensure that oxidation of both Grx1roGFP2 and HyPer7 causes an increase in ratio.</p>
</sec>
<sec id="s2-10">
<title>2.10 Data collection and analysis</title>
<p>Unless otherwise noted, the data are expressed as means &#xb1; SEM of three independent experiments, each performed in technical triplicate. With the exception of <xref ref-type="fig" rid="F4">Figure 4</xref>, statistics were evaluated by comparing two data groups using an unpaired <italic>t</italic>-test with <italic>p</italic> &#x3c; 0.05 as the standard criteria for significance. GraphPad Prism 8.0 (GraphPad Software, San Diego, CA, United States) was used to generate plots and to perform statistical analysis.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Higher basal activity and altered Ca<sup>2&#x2b;</sup> sensitivity of NFAT in HEK293 TKO cells</title>
<p>To investigate the impact of Ca<sup>2&#x2b;</sup> signal loss on transcription, we began by looking at the activation of the well-established Ca<sup>2&#x2b;</sup>-dependent transcription factor NFAT using a luciferase reporter assay. We expressed the effect of treatments as a fold-activation over the baseline of WT cells, after normalization for transfection efficiency using Renilla luciferase activity. However, a 50%&#x2013;70% increase in baseline NFAT activity was noted in both HEK293 and HeLa TKO cells (<xref ref-type="fig" rid="F1">Figures 1A,C</xref>). HEK293 cells express endogenous M3 muscarinic receptors (<xref ref-type="bibr" rid="B44">Luo et al., 2008</xref>) and stimulation with carbachol (Cch) caused a 3.5-fold increase in NFAT activity in WT cells, but had no further stimulatory effect above the baseline of TKO cells (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Activation of endogenous histamine receptors in HeLa cells showed a 2-fold activation of NFAT in WT cells which is lost in TKO cells (<xref ref-type="fig" rid="F1">Figure 1C</xref>). These observations are in line with published data showing loss of NFAT stimulation by B-cell receptor activation in DT40 TKO cells (<xref ref-type="bibr" rid="B73">Sugawara et al., 1997</xref>), and reduced NFAT activation in HEK293A&#xa0;cells after siRNA knockdown of type 2 IP<sub>3</sub>Rs (<xref ref-type="bibr" rid="B6">Arguin et al., 2010</xref>). As a control to verify that NFAT was still responsive to Ca<sup>2&#x2b;</sup> in TKO cells, we tested the effect of the Ca<sup>2&#x2b;</sup> ionophore ionomycin which had comparable effects to agonists in both WT HEK293 and HeLa cells. However, ionophore elicited an unexpectedly large increase (&#x223c;13-fold activation) in NFAT activity in the HEK293 TKO cells (<xref ref-type="fig" rid="F1">Figure 1A</xref>). An increased NFAT response to thapsigargin-induced elevation of cytosolic Ca<sup>2&#x2b;</sup> was also observed in HEK293 TKO cells (<xref ref-type="fig" rid="F1">Figure 1B</xref>). Previous studies have shown equivalent responses of [Ca<sup>2&#x2b;</sup>]<sub>c</sub> to ionomycin and thapsigargin in HEK293 TKO cells (<xref ref-type="bibr" rid="B11">Bittremieux et al., 2017</xref>; <xref ref-type="bibr" rid="B87">Yue et al., 2020</xref>; <xref ref-type="bibr" rid="B86">Young et al., 2022</xref>; <xref ref-type="bibr" rid="B15">Chakraborty et al., 2023</xref>). The hypersensitivity to ionomycin was not observed in the HeLa TKO model. These results suggest that one adaptation to a loss of Ca<sup>2&#x2b;</sup> signaling in HEK293 TKO cells is an increased Ca<sup>2&#x2b;</sup> sensitivity of the calcineurin (CaN) -mediated dephosphorylation of NFAT. Immunosuppressive drugs (e.g., cyclosporine A or FK506) are known to block NFAT activation by inhibition of calcineurin activity (<xref ref-type="bibr" rid="B50">Mattila et al., 1990</xref>). To test for the involvement of CaN we pretreated the cells with cyclosporine A (CsA) which blocked the ionomycin responses in both WT and TKO HEK 293 cells and eliminated the baseline differences seen in the TKO cells (<xref ref-type="fig" rid="F1">Figure 1A</xref>). The enhanced sensitivity of TKO cells to thapsigargin was also inhibited by CsA (<xref ref-type="fig" rid="F1">Figure 1B</xref>). Many possible mechanisms may underlie the altered Ca<sup>2&#x2b;</sup> sensitivity of CaN regulation in HEK293 TKO cells, including a slower export of NFAT from the nucleus or altered levels of endogenous CaN inhibitors such as RCAN1 (<xref ref-type="bibr" rid="B46">Macian, 2005</xref>). We found decreased levels of RCAN1 in HEK293 TKO cells but not in HeLa TKO cells (<xref ref-type="fig" rid="F1">Figure 1D</xref>), which would be consistent with hypersensitivity to ionomycin being confined to HEK293 cells. Another reason for the lack of Ca<sup>2&#x2b;</sup> hypersensitivity could be related to HeLa cells having a different complement of NFAT isoforms than HEK293 cells (<xref ref-type="bibr" rid="B8">Bekker-Jensen et al., 2017</xref>), since each isoform also shows differential regulation and kinetics of nuclear translocation (<xref ref-type="bibr" rid="B30">Kar and Parekh, 2015</xref>; <xref ref-type="bibr" rid="B85">Yoast et al., 2020</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>NFAT activity in wild-type and IP<sub>3</sub>R TKO cells. <bold>(A)</bold> HEK293 WT (black) and TKO (red) cell lines were co-transfected with fire-fly NFAT-luciferase and <italic>Renilla</italic> luciferase reporter vectors. After 24h, cells were treated for a further 4&#xa0;h with either 25&#xa0;&#x3bc;M carbachol (Cch), 200&#xa0;nM Ionomycin (Iono) or 100&#xa0;nM PMA. When used, 0.5&#xa0;&#x3bc;M cyclosporine A (CsA) was preincubated for 30min. Lysates were assayed for luciferase activity as given in &#x2018;Experimental Procedures&#x2019;. All fire-fly/Renilla luciferase ratios were normalized to the value obtained for WT cells at baseline. Statistical significance &#x2a;<italic>p</italic> &#x3c; 0.05; &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001; ns &#x3d; not significant. <bold>(B)</bold> HEK293 cells were treated with 0.5&#xa0;&#xb5;M Thapisgargin (Tg) in the presence or absence of cyclosporine A (CsA) pretreatment as in <bold>(A, C)</bold> HeLa WT (black) and TKO (red) cell lines were treated with 25&#xa0;&#xb5;M Histamine (His) and other reagents as described in <bold>(A, D)</bold> HEK293 and HeLa WT (black) and TKO (red) cell lines were immunoblotted for RCAN1. In the lower panel RCAN1 levels were normalized to GAPDH and quantitated. The data shown are the mean &#xb1; S.E.M.of 3 independent experiments.</p>
</caption>
<graphic xlink:href="fcell-12-1473210-g001.tif"/>
</fig>
<p>Many NFAT-dependent target genes are also stimulated by the AP-1 transcription factor, which in turn is activated by PKC signaling (<xref ref-type="bibr" rid="B25">Hogan et al., 2003</xref>). The cooperative binding of NFAT and AP-1 to adjacent promoter sites results in synergistic activation of NFAT gene targets when cells are simultaneously stimulated by Ca<sup>2&#x2b;</sup> and PKC activation (<xref ref-type="bibr" rid="B47">Macian et al., 2001</xref>). A pan PKC activator, phorbol 12-myristate 13-acetate (PMA), caused a &#x223c;70% activation of NFAT in the HEK293 WT or TKO cell line (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Combination treatment of PMA and ionomycin elicited synergistic responses in WT and TKO cells. However, the PMA/ionomycin treatment caused a larger increase in the TKO cells (45-fold <italic>versus</italic> 12-fold in WT cells). A synergistic activation by PMA/ionomycin was seen in the HeLa WT line (<xref ref-type="fig" rid="F1">Figure 1C</xref>). However, in HeLa TKO cells, PMA alone caused a large NFAT activation which was not further stimulated when combined with ionomycin (<xref ref-type="fig" rid="F1">Figure 1C</xref>).</p>
</sec>
<sec id="s3-2">
<title>3.2 Higher basal activity, altered Ca<sup>2&#x2b;</sup> sensitivity and increased reliance on Ca<sup>2&#x2b;</sup> independent PKC for CREB activation in TKO cells</title>
<p>Next, we investigated cAMP response element binding protein (CREB), another well studied Ca<sup>2&#x2b;</sup>-sensitive transcription factor (<xref ref-type="bibr" rid="B71">Steven et al., 2020</xref>). Using a CRE-luciferase reporter assay to monitor the activity of CREB, we observed baseline increases in both HEK293 and HeLa TKO cells (<xref ref-type="fig" rid="F2">Figures 2A,B</xref>). Unlike NFAT, CREB luciferase activity was still stimulated by agonists in TKO cells of both cell types. The addition of ionomycin to the WT cells had a smaller effect than agonist on CREB-luciferase activity. However, ionomycin promoted a marked increase in CREB reporter activity (&#x3e;10-fold) in HEK293 TKO cells. CsA blocked the effects of ionomycin and eliminated the baseline increase in CREB reporter activity seen in the TKO cells (<xref ref-type="fig" rid="F2">Figure 2A</xref>). The supersensitivity to ionophore was not observed in HeLa TKO cells which were actually less sensitive to ionophore compared to WT cells (<xref ref-type="fig" rid="F2">Figure 2B</xref>). The selective effect of ionomycin resembles that seen with NFAT luciferase in HEK293 cells (<xref ref-type="fig" rid="F1">Figure 1A</xref>) and may have the same underlying mechanism. It is known that CaN can activate CREB by dephosphorylation and nuclear translocation of CRTC2, a transcriptional coactivator of CREB (<xref ref-type="bibr" rid="B68">Screaton et al., 2004</xref>). Thus, decreased levels of RCAN1 could play the same role in altering the Ca<sup>2&#x2b;</sup> responsiveness of CREB in a manner similar to NFAT. The different ionophore response in HeLa cells may be due to the lack of RCAN1 changes, but it should be noted that the regulation of CRTC2 is also different in HeLa cells since they lack an upstream kinase (LKB1) needed to maintain phosphorylation of CRTC2 (<xref ref-type="bibr" rid="B32">Katoh et al., 2006</xref>). In a previously published study on HEK293A&#xa0;cells it was shown that optimal responses of CREB to Ca<sup>2&#x2b;</sup> mobilizing hormone requires the addition of vasoactive intestinal peptide (VIP), a cAMP-elevating stimulus (<xref ref-type="bibr" rid="B6">Arguin et al., 2010</xref>). Treatment with VIP alone or in combination with ionophore caused a very large activation of CREB in both cell lines which was not significantly different in the TKO cells (<xref ref-type="fig" rid="F2">Figures 2A,B</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>CREB activity in wild-type and IP<sub>3</sub>R TKO cells. <bold>(A)</bold> HEK293 WT (black) and TKO (red) cell lines were co-transfected with fire-fly CRE-luciferase and <italic>Renilla</italic> luciferase reporter vectors. Treatment conditions and data analysis were as described for Fig 1A. Vasoactive intestinal peptide (VIP) was used at 0.5&#xa0;&#x3bc;M. <bold>(B)</bold> HeLa WT (black) and TKO (red) cell lines were treated with reagents as described in Panel A except 25&#xa0;&#x3bc;M Histamine (His) was used as agonist. <bold>(C)</bold> Representative immunoblots for pCREB (ser-133) and total CREB in HEK293 WT and TKO lysates are shown. Cells were treated for 10min with 25&#xa0;&#xb5;M carbachol (Cch), 1&#xa0;&#x3bc;M Ro-31&#x2013;8220 (Ro-31), a pan-PKC inhibitor, or both. In the lower panel p-CREB data was expressed as a ratio of total CREB and normalized to baseline WT values. <bold>(D)</bold> Representative immunoblots and quantitation of pCREB in HeLa WT and TKO lysates are shown. Conditions were the same as used for <bold>(C)</bold> except for the use of 25&#xa0;&#x3bc;M Histamine (His) as agonist. <bold>(E)</bold> HEK293 WT and TKO cells were transfected with scrambled siRNA (Scr) or siRNA for PKC&#x3b4; for 48&#xa0;h and expression levels of PKC&#x3b4; was measured by immunoblotting using GAPDH as a loading control. Expression was normalized to WT levels and the data shown are the mean &#xb1; S.E.M. of 3 independent experiments. <bold>(F)</bold> HEK293 WT and TKO cells were transfected with siRNA as described in <bold>(E)</bold> and then stimulated for 10min with 25&#xa0;&#x3bc;M carbachol (Cch). Changes in p-CREB and total CREB were measured by immunoblotting. Fold activation by Cch was quantitated in 3 experiments in the lower panel. <bold>(G, H)</bold> Conditions were the same as described for <bold>(E, F)</bold> except HeLa WT and TKO cells were used and were stimulated with 25&#xa0;&#x3bc;M Histamine (His) as agonist. In <bold>(C,D,F, H)</bold> separate gels were used to measure phospho- and total CREB.</p>
</caption>
<graphic xlink:href="fcell-12-1473210-g002.tif"/>
</fig>
<p>A primary phosphorylation site in CREB is at ser-133 which enhances recruitment of the co-activator CBP/p300 and increases transcriptional activity (<xref ref-type="bibr" rid="B29">Johannessen et al., 2004</xref>). To confirm the data obtained with CREB reporter assays, we immunoblotted for p-CREB (ser-133) after 10min agonist treatment in HEK293 (<xref ref-type="fig" rid="F2">Figure 2C</xref>) and HeLa (<xref ref-type="fig" rid="F2">Figure 2D</xref>) cells and increased CREB phosphorylation in both WT and TKO cells, with agonist effects being significantly larger in the TKO cell lines (<xref ref-type="fig" rid="F2">Figures 2C,D</xref>). Ca<sup>2&#x2b;</sup>-modulation of CREB is exerted through phosphorylation by specific isoforms of two protein kinase families, Ca<sup>2&#x2b;</sup>/calmodulin-dependent protein kinase (CaMK) and PKC (<xref ref-type="bibr" rid="B18">Dewenter et al., 2017</xref>; <xref ref-type="bibr" rid="B71">Steven et al., 2020</xref>). To investigate the possible role of PKC in maintaining CREB phosphorylation in TKO cells, we used a pan-PKC inhibitor, Ro-31&#x2013;8220 (<xref ref-type="bibr" rid="B55">Nixon et al., 1992</xref>). The inhibitor did not block agonist-stimulated pCREB in WT HEK293 or HeLa cells suggesting that PKC is not a major factor controlling CREB phosphorylation in WT cells. However, the pan-PKC inhibitor decreased phosphorylation in both TKO cell lines (<xref ref-type="fig" rid="F2">Figures 2C,D</xref>). In order to identify the isoform of PKC that may be involved in maintaining CREB activation in TKO cells we used an siRNA knockdown approach. The obvious candidates are the novel Ca<sup>2&#x2b;</sup>-insensitive isoforms, of which PKC&#x3b4; and PKC&#x3b5; are both expressed in HEK293 and HeLa cells (<xref ref-type="bibr" rid="B62">Rimessi et al., 2007</xref>; <xref ref-type="bibr" rid="B34">Kim et al., 2016</xref>). HEK293 WT and TKO cells expressed similar basal levels of total PKC&#x3b4; and treatment with siRNA resulted in &#x3e;90% knockdown in both cell lines. (<xref ref-type="fig" rid="F2">Figure 2E</xref>). Knockdown of PKC&#x3b4; had no effect on agonist stimulated CREB phosphorylation in HEK293 WT cells but caused a 50% reduction of pCREB in TKO cells (<xref ref-type="fig" rid="F2">Figure 2F</xref>). In HeLa cells, expression levels of basal PKC&#x3b4; in TKO cells was only 25% of that seen in WT cells (<xref ref-type="fig" rid="F2">Figure 2G</xref>). The mechanism(s) involved were not further explored but it is known that PKC&#x3b4; is targeted for degradation by phosphorylation and ubiquitination (<xref ref-type="bibr" rid="B70">Srivastava et al., 2002</xref>). Treatment with siRNA reduced PKC&#x3b4; in HeLa WT and TKO cells but resulted in significantly reduced pCREB only in TKO cells (<xref ref-type="fig" rid="F2">Figure 2H</xref>). The poor quality of our PKC&#x3b5; antibodies precluded further investigation of the contribution of this isoform. Overall, these data indicate that CREB activation is maintained in TKO cells, in part, by an increased reliance on Ca<sup>2&#x2b;</sup>-insensitive PKC isoforms.</p>
</sec>
<sec id="s3-3">
<title>3.3 AP-1 is constitutively active in TKO cells</title>
<p>AP-1 is a transcription factor composed of homo- and heterodimers of members of the fos, jun, Maf and ATF families. These proteins are categorized as &#x201c;immediate early genes&#x201d; that are normally present at low amounts in quiescent cells and are induced in response to activation of signaling pathways, such as Ca<sup>2&#x2b;</sup> mobilization or the activation of PKC. Initially, we examined the activity of AP-1 in WT and TKO cells using luciferase promoter assays (<xref ref-type="fig" rid="F3">Figure 3</xref>). The results show that agonists only weakly stimulated AP-1 activity (&#x3c;20%) in the WT HEK293 (<xref ref-type="fig" rid="F3">Figure 3A</xref>) but increased AP-1 activity in WT HeLa cells (<xref ref-type="fig" rid="F3">Figure 3B</xref>) by &#x223c;2-fold. Both TKO cell lines had elevated baseline AP-1 activities, which could not be further increased by agonists. AP-1 activity in HEK293 cells was not responsive to ionomycin but was stimulated by PMA. This is in line with the known sensitivity of AP-1 to activation by PKC (<xref ref-type="bibr" rid="B31">Karin et al., 1997</xref>). Although PMA treatment of TKO cells gave an apparent smaller fold activation in both cell types, the absolute levels of AP-1 activity were comparable when the elevated baselines were taken into account. The combined treatment with PMA and ionomycin produced a synergistic activation in both WT and TKO HEK293 cells but not in HeLa cells. The elevated baselines of AP-1, NFAT and CREB reporter activities could be suppressed in HEK293 TKO cells stably rescued with the human IP<sub>3</sub>R1 isoform (<xref ref-type="sec" rid="s11">Supplementary Figure S1</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>AP-1 activity in wild-type and IP<sub>3</sub>R TKO cells. <bold>(A)</bold> HEK293 WT (black) and TKO (red) cell lines were co-transfected with fire-fly AP1-luciferase and <italic>Renilla</italic> luciferase reporter vectors. Treatment conditions and data analysis were as described for <xref ref-type="fig" rid="F1">Figure 1A</xref>. <bold>(B)</bold> HeLa WT (black) and TKO (red) cell lines were treated with reagents as described in Panel A except 25&#xa0;&#x3bc;M Histamine (His) was used as agonist. <bold>(C)</bold> Lysates were prepared from HEK293 WT and TKO cells treated with the indicated concentrations of Cch for 4&#xa0;h. Samples were immunoblotted for c-fos and quantitated using GAPDH as a loading control <bold>(G)</bold>. Data were normalized to the WT unstimulated values. <bold>(D)</bold> fosB; <bold>(E)</bold> c-jun; <bold>(F)</bold> junB. The data shown are the mean &#xb1; S.E.M. of 3 independent experiments. All data are statistically significant from WT unstimulated values at <italic>p</italic> &#x3c; 0.05 with only the data not significantly different marked &#x201c;ns&#x201d;.</p>
</caption>
<graphic xlink:href="fcell-12-1473210-g003.tif"/>
</fig>
<p>The protein expression levels of four AP-1 members (c-fos, fosB, c-jun, junB) were examined by immunoblotting of control and agonist-stimulated HEK293 WT and TKO cells (<xref ref-type="fig" rid="F3">Figures 3C&#x2013;G</xref>). Significant levels of c-fos, c-jun and junB were detected at baseline even in serum-deprived HEK293 cells. In the case of c-fos, basal levels were comparable in WT and TKO cells and carbachol treatment increased c-fos similarly in both cell lines, although higher concentrations of carbachol were required in TKO cells (<xref ref-type="fig" rid="F3">Figure 3C</xref>). By contrast, baseline fosB was not detectable in WT or TKO cells and was increased by carbachol treatment only in WT cells (<xref ref-type="fig" rid="F3">Figure 3D</xref>). Two bands were detected for fosB with both bands showing the same changes. Based on its molecular weight, the lower band likely corresponds to the molecular weight of the established splice variant fosB2 (also known as delta fosB) (<xref ref-type="bibr" rid="B54">Nakabeppu and Nathans, 1991</xref>). c-Jun (<xref ref-type="fig" rid="F3">Figure 3E</xref>) and JunB (<xref ref-type="fig" rid="F3">Figure 3F</xref>) behaved similarly, with protein levels increasing in response to carbachol in WT cells. However, baseline levels of both proteins were elevated in TKO cells and could not be further stimulated by carbachol treatment. Changes in the levels of these AP-1 proteins in WT and TKO HeLa cells are shown in <xref ref-type="sec" rid="s11">Supplementary Figure S3</xref>. c-Fos and JunB in HeLa cells behaved in a manner similar to c-jun and JunB in HEK cells. Notably, baseline levels were increased in TKO cells and could not be further stimulated by histamine. The histamine response of c-jun was decreased in TKO cells and FosB was not expressed in HeLa cells under any experimental conditions (not shown). The results indicate that some members of the AP-1 family are more highly expressed at baseline in TKO cells and this could underlie the constitutive activation of AP-1 activity seen under these conditions.</p>
</sec>
<sec id="s3-4">
<title>3.4 MAP kinase and NF&#x3ba;b activities are maintained in TKO cells</title>
<p>The activation of ERK1/2, p38 and Jnk MAP kinase cascades lie upstream of the AP-1 and CREB pathways. The consensus of studies suggests that while Ca<sup>2&#x2b;</sup> signals are not essential, they can regulate these pathways. For example, Ca<sup>2&#x2b;</sup> elevation in primary cortical neurons (<xref ref-type="bibr" rid="B66">Rosen et al., 1994</xref>; <xref ref-type="bibr" rid="B2">Agell et al., 2002</xref>), fibroblasts (<xref ref-type="bibr" rid="B16">Chao et al., 1994</xref>) and HeLa cells (<xref ref-type="bibr" rid="B37">Kupzig et al., 2005</xref>) activates the Ras/Raf/ERK1/2 pathway. Similarly, there have been many studies which report the involvement of a Ca<sup>2&#x2b;</sup> signal in the activation of p38 and Jnk (<xref ref-type="bibr" rid="B20">Enslen et al., 1996</xref>) pathways. We have examined the carbachol-mediated activation of Jnk and ERK1/2 in HEK293 TKO cells (<xref ref-type="sec" rid="s11">Supplementary Figure S3</xref>). In the case of Jnk, a 54&#xa0;kDa species was phosphorylated in response to carbachol stimulation in both WT and TKO cells (<xref ref-type="sec" rid="s11">Supplementary Figures SA&#x2013;C</xref>). However, a higher baseline level and more rapid kinetics of p-Jnk formation were evident in the TKO cells. Similarly, the ERK1/2 pathway was activated robustly by carbachol in both WT and TKO cells (<xref ref-type="sec" rid="s11">Supplementary Figures S3D, E</xref>).</p>
<p>Multiple mechanisms have been identified for the Ca<sup>2&#x2b;</sup> regulation of NF&#x3ba;b activity including activation of PKC (<xref ref-type="bibr" rid="B10">Berry et al., 2018</xref>). A NF&#x3ba;b luciferase promoter showed a higher basal activity in HEK293 TKO cells but was insensitive to carbachol or ionophore in either WT or TKO cells (<xref ref-type="sec" rid="s11">Supplementary Figures S3F, E</xref>). As expected PMA was a potent stimulus for NF&#x3ba;b promoter activity but the combination of ionophore and PMA was less effective, particularly in TKO cells (<xref ref-type="sec" rid="s11">Supplementary Figure S3</xref>). HeLa WT and TKO cells showed several differences from HEK293 cells including similar baseline activity and less pronounced sensitivity to PMA (<xref ref-type="sec" rid="s11">Supplementary Figure S3G</xref>). In contrast to lymphocytes, the NF&#x3ba;b pathway appears relatively insensitive to Ca<sup>2&#x2b;</sup> changes even in WT HEK293 and HeLa cells.</p>
</sec>
<sec id="s3-5">
<title>3.5 ROS handling is altered in TKO cells</title>
<p>Increased ROS levels regulate the basal activity of many transcription factors including NFAT (<xref ref-type="bibr" rid="B79">Vaeth and Feske, 2018</xref>; <xref ref-type="bibr" rid="B58">Peng et al., 2021</xref>), AP-1 (<xref ref-type="bibr" rid="B1">Abate et al., 1990</xref>), NF&#x3ba;b (<xref ref-type="bibr" rid="B51">Morgan and Liu, 2011</xref>) and CREB (<xref ref-type="bibr" rid="B27">Ichiki et al., 2003</xref>). In addition, the activity of specific signaling proteins, e.g., Jnk are altered by ROS (<xref ref-type="bibr" rid="B3">Aggarwal et al., 2019</xref>). Therefore, we examined if ROS production is altered in the IP<sub>3</sub>R TKO cells. Initially, we measured the production of extracellular H<sub>2</sub>O<sub>2</sub> using a peroxidase/amplex red assay. The results showed increased H<sub>2</sub>O<sub>2</sub> release in both HEK293 and HeLa TKO cells under basal conditions (<xref ref-type="fig" rid="F4">Figures 4A,B</xref>). As a positive control we treated cells with antimycin A (AA) which blocks electron flow at complex III and stimulates production of superoxide (O<sub>2</sub>
<sup>&#x2022;&#x2500;</sup>) (<xref ref-type="bibr" rid="B60">Quinlan et al., 2011</xref>) that can be enzymatically converted to H<sub>2</sub>O<sub>2</sub> by superoxide dismutase (SOD). Both WT and TKO cells showed a stimulation of H<sub>2</sub>O<sub>2</sub> when treated with AA (<xref ref-type="fig" rid="F4">Figures 4A,B</xref>). Further inhibition of the, ETC with the combination of AA and rotenone blocks electron entry to the, ETC and acts as a negative control. In both HEK293 and HeLa TKO cells the AA and rotenone cocktail was insufficient to block H<sub>2</sub>O<sub>2</sub> release. However, in both HEK293 and HeLa the AA and rotenone cocktail did not eliminate the difference between WT and TKO cells suggesting an, ETC independent source of H<sub>2</sub>O<sub>2</sub> in TKO cells. We employed diphenyleneiodonium (DPI) as an isoform insensitive inhibitor of NADPH oxidase (NOX) complex assembly. In both HEK and HeLa, NOX inhibition had a more pronounced effect in TKO cells vs. WT. It should be noted that NOX expression is regulated by some of the transcription factors shown to be increased in TKO cells (e.g., AP-1 and NF&#x3ba;B (<xref ref-type="bibr" rid="B48">Manea et al., 2015</xref>)) and NOX activity can be increased by PKC&#x3b4; (<xref ref-type="bibr" rid="B35">Kim et al., 2011</xref>). As predicted, inhibition of catalase activity with 3-aminotriazole (3-AT) increased H<sub>2</sub>O<sub>2</sub> release in both HEK and HeLa TKO cells (<xref ref-type="fig" rid="F4">Figures 4A,B</xref>). Inhibition of H<sub>2</sub>O<sub>2</sub> metabolism could also contribute to the elevation of H<sub>2</sub>O<sub>2</sub> in TKO cells. However, direct measurements of the catalytic activity of glutathione peroxidase showed a small decrease that was confined to HEK293 TKO cells only (<xref ref-type="sec" rid="s11">Supplementary Figure S4A</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>ROS handling is altered in IP<sub>3</sub>R TKO cells. <bold>(A)</bold> The rate of extracellular H<sub>2</sub>O<sub>2</sub> generation was measured with Amplex Red in WT and TKO HEK293 cells grown in 96 well plates as described in &#x2018;Experimental Procedures&#x2019;. Antimycin A (AA; 0.5&#xa0;&#x3bc;M) was used as a positive control while AA and Rotenone (Rot; 5&#xa0;&#xb5;M), diphenyleneiodonium chloride (DPI; 5&#xa0;&#xb5;M) and 3-aminotriazole (3-AT; 5&#xa0;mM) were used to inhibit the electron transport chain, NADPH oxidase and catalase respectively. The data shown are box plots showing mean (small box), median (horizontal line) 25th and 75th percentile (box) and 1.5 x interquartile range (whiskers). Statistics are one-way ANOVA following a normality test and subject to Tukey <italic>post hoc</italic> analysis. &#x2a;-&#x2a;&#x2a;&#x2a;&#x2a; represents <italic>p</italic> &#x2264; 0.05- <italic>p</italic> &#x2264; 0.0001 respectively. <bold>(B)</bold> Conditions were as in <bold>(A)</bold> but using HeLa WT and TKO cells. <bold>(C)</bold> Mitochondrial superoxide was measured in WT and TKO HEK293 cells grown in 96 well plates with MitoSox. The data shown are individual measurements made in 3 separate experiments with the data normalized to the mean value of WT cells. <bold>(E&#x2013;H)</bold> Key antioxidant enzyme levels were immunoblotted in HEK293 and HeLa lysates using tubulin as the loading control. Data were quantitated and normalized to the WT unstimulated values. The data are the mean &#xb1; S.E.M. of 3 independent experiments. All data are statistically significant from WT unstimulated values at <italic>p</italic> &#x3c; 0.05 with only the data not significantly different marked &#x201c;ns&#x201d;. <bold>(E)</bold> Superoxide dismutase-1 (SOD1). <bold>(F)</bold> Superoxide dismutase-2. <bold>(G)</bold> Catalase. <bold>(H)</bold> Tubulin. <bold>(I)</bold> HEK293 and HeLa WT (black) and TKO (red) cell lines were co-transfected with Nrf2/ARE-luciferase and <italic>Renilla</italic> luciferase reporter vectors. After 24&#xa0;h, cells lysates were assayed for promoter activity.</p>
</caption>
<graphic xlink:href="fcell-12-1473210-g004.tif"/>
</fig>
<p>We attempted to quantitate O<sub>2</sub>
<sup>&#x2022;&#x2500;</sup> generation directly using the mitochondrial targeted probe MitoSox (<xref ref-type="bibr" rid="B52">Murphy et al., 2022</xref>). These results showed that O<sub>2</sub>
<sup>&#x2022;&#x2500;</sup> levels are decreased under basal and AA-treated conditions in both HEK293 and HeLa TKO cells (<xref ref-type="fig" rid="F4">Figures 4C,D</xref>). The result would be consistent with an increased conversion of O<sub>2</sub>
<sup>&#x2022;&#x2500;</sup> to H<sub>2</sub>O<sub>2</sub> by SOD in TKO cells. Indeed, levels of the cytosolic (SOD1) and the mitochondrial (SOD2) isoforms were increased in HEK293 TKO cells (<xref ref-type="fig" rid="F4">Figures 4E,F,H</xref>). However, only the mitochondrial SOD2 isoform was elevated in HeLa TKO cells (<xref ref-type="fig" rid="F4">Figures 4E,F</xref>). Catalase protein levels were also elevated in both cell types (<xref ref-type="fig" rid="F4">Figure 4G</xref>). The presence of altered handling of ROS in TKO cells was further confirmed by using two additional approaches. The first was to monitor the redox status of glutathione in the cytosol and mitochondrial compartments using the genetically targeted Grx1-roGFP2 probe (<xref ref-type="bibr" rid="B23">Gutscher et al., 2008</xref>). The results showed the cytosolic glutathione pool was more reduced in the TKO cells but the mitochondrial pool was not affected (<xref ref-type="sec" rid="s11">Supplementary Figure S4B</xref>). The second approach was to use HyPer7-an ultra-sensitive, pH independent, H<sub>2</sub>O<sub>2</sub> probe targeted to the cytosol (<xref ref-type="bibr" rid="B57">Pak et al., 2020</xref>). Using additions of H<sub>2</sub>O<sub>2</sub> and DTT to provide maximum and minimum values, the HyPer7 probe confirmed that HEK293 TKO cells maintained a higher baseline production of H<sub>2</sub>O<sub>2</sub> (<xref ref-type="sec" rid="s11">Supplementary Figure S4C</xref>) and that AA was able to further increase the signal in both WT and TKO cells. Some of the functional effects of ROS on gene transcription are mediated by the transcription factor Nrf2 which translocates to the nucleus and binds antioxidant response elements (ARE) in the promoters of genes coding for antioxidant enzymes (including catalase and SOD&#x2019;s) (<xref ref-type="bibr" rid="B45">Ma, 2013</xref>). Measurement of luciferase promoter activity indicates that basal activity of Nrf2/ARE was increased in both HEK293 and HeLa TKO cells, consistent with enhanced ROS generation (<xref ref-type="fig" rid="F4">Figure 4I</xref>).</p>
</sec>
<sec id="s3-6">
<title>3.6 RNAseq analysis of HEK293 and HeLa TKO cell model</title>
<p>To gain a broader understanding of global baseline transcriptional changes resulting from knockout of IP<sub>3</sub> receptors, we carried out RNAseq analysis on unstimulated WT and TKO cell models in both HEK293 and HeLa lines. For HEK293 cells a total of 58,825 gene transcripts were measured and 828 genes were identified as being differentially expressed (DEG) by edgeR analysis using a criteria of &#x2223;log<sub>2</sub> fold change&#x2223;&#x3e;1 and <italic>p</italic>-value &#x3c; 0.05. These genes are depicted on a volcano plot in <xref ref-type="fig" rid="F5">Figure 5A</xref> with the top 30 genes having highest statistical significance (false discovery rate <italic>p</italic>-value &#x3c; 0.01) being colored and labeled. In order to determine if there were changes in groups of genes with related biological function, we also compared the DEGs to online curated gene sets encoding Ca<sup>2&#x2b;</sup> signaling components, transcription factors or mitochondrial proteins (<xref ref-type="fig" rid="F5">Figure 5B</xref>). Six cell surface receptors coupled to phospholipase-C activation are in the Ca<sup>2&#x2b;</sup> signaling list but the biological relevance of these changes are likely to be complicated since some are upregulated (e.g., HTR2C, CCKBR) and others downregulated (e.g., EGFR, P2RY11). Six cation channels are also in the list including several members of the TRP family. This includes TRPC6, which can be directly stimulated by diacylglycerol, and is known to be involved in NFAT activation in the heart (<xref ref-type="bibr" rid="B38">Kuwahara et al., 2006</xref>). All these channels, with one exception (KCNN3), were upregulated in the TKO cells. In the case of transcription factors, the list included 8 immediate early genes (underlined), all of which were downregulated under basal conditions. Only a few genes encoding mitochondrial proteins were altered. In many cases, such as acyl CoA synthetases (ACSL6, ACSL1) or respiratory complexes (NDUFA6, SCO2) the changes were in opposite directions. Transcripts for MICU2 were also decreased in TKO cells but previous studies have shown that the levels of protein were not altered (<xref ref-type="bibr" rid="B33">Katona et al., 2022</xref>). The over representation of DEGs in specific KEGG pathways was assessed in <xref ref-type="fig" rid="F5">Figure 5C</xref>. The top 20 hits included several signaling pathways, such as phospholipase D, MAPK, and VEGF. Of particular interest, the NF&#x3ba;B signaling pathway was highlighted as being significantly enriched in the TKO cells which is in line with results from the NF&#x3ba;b luciferase reporter assays. Focal adhesion was also a highlighted KEGG pathway. Although not specifically investigated in this study, others have reported decreased motility of IP<sub>3</sub>R TKO HEK293 cells (<xref ref-type="bibr" rid="B87">Yue et al., 2020</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Analysis of the HEK293 RNAseq data set for Wild-type <italic>versus</italic> IP<sub>3</sub>R TKO cells. <bold>(A)</bold>. Distribution of the 828 differentially expressed genes is shown as a volcano plot. The default cut off for FDR was set at 1% and &#x7c;log<sub>2</sub> FC&#x7c; &#x3e;1. The top 30 genes are indicated. <bold>(B)</bold>. Manually curated gene sets for Ca<sup>2&#x2b;</sup> signaling pathways, transcription factors and mitochondrial genes (MitoCarta 3.0) were used to identify hits within the DEG gene list. The significance level of the gene changes measured by FDR is indicated in the inset. Genes in black were upregulated and genes in blue were downregulated. The origin of the curated gene sets are given in &#x201c;Materials and Methods&#x201d;. <bold>(C)</bold>. Bubble plot of KEGG enrichment analysis of DEGs. Top 20 KEGG pathways (<italic>p</italic> &#x2264; 0.05) are presented. <italic>Y</italic>-axis represents pathways; <italic>X</italic>-axis represents rich factor; (rich factor equals the ratio between the DEGs and all annotated genes enriched in the pathway). The color and size of each bubble represent enrichment significance and the number of DEGs enriched in a pathway, respectively.</p>
</caption>
<graphic xlink:href="fcell-12-1473210-g005.tif"/>
</fig>
<p>To look for cell type dependent and independent changes, we repeated the RNAseq analysis in HeLa WT and TKO cell models (<xref ref-type="fig" rid="F6">Figure 6</xref>). For HeLa cells a total of 60,613 gene transcripts were measured and 310 genes were identified as being differentially expressed (DEG) by edgeR analysis using the same threshold criteria as used for HEK293 cells. Based on this the number of DEGs are significantly lower in HeLa cells (37.4%). These genes are depicted on a volcano plot in <xref ref-type="fig" rid="F6">Figure 6A</xref> with the top 30 genes being identified as in <xref ref-type="fig" rid="F5">Figure 5A</xref>. A feature that is apparent is that many more genes are downregulated than upregulated in HeLa cells, whereas the opposite is true for HEK293 cells. The distribution of the HeLa DEGs within the curated gene sets of Ca<sup>2&#x2b;</sup> signaling, transcription factors or mitochondrial proteins are shown in <xref ref-type="fig" rid="F6">Figure 6B</xref>. As expected, a lower number of genes are found in each category than seen for HEK293 cells. The over-representation analysis also showed no overlap in the 2&#xa0;cell types with a lower number of HeLa DEGs in each KEGG gene set (<xref ref-type="fig" rid="F6">Figure 6C</xref>). At the single gene level with the significance criteria used, there were only 18 genes changed in common between the HEK293 and HeLa data sets (<xref ref-type="fig" rid="F7">Figure 7</xref>). To avoid focusing on individual genes, or DEG lists based on thresholds, we utilized gene set enrichment analysis (GSEA) which uses all the genes in the RNAseq data set to look for concerted changes in biological pathways. This analysis, using the Hallmark gene set from the Molecular Signatures data base, is shown for HEK293 (<xref ref-type="fig" rid="F7">Figure 7C</xref>) and HeLa cells (<xref ref-type="fig" rid="F7">Figure 7D</xref>). More pathways were enriched than de-enriched in HEK293 cells than in HeLa cells, in line with our previous analysis of individual genes. Ten common pathways were altered in the same direction in both cell types under basal conditions. This included KRAS signaling, TNF-alpha signaling via NF-Kb, Interferon responses, Notch signaling, hypoxia and the p53 pathway. However, there were also changes in pathways that were unique or changed in opposite directions in both cell types.It is possible that the changes in the common pathways may underlie the common changes in phenotypes observed in the two TKO cell lines&#x2013;notably, increased baseline transcription factor activity, altered PKC regulation and elevated ROS levels. However, the relationships between the common pathways and common phenotypes are likely to be complex. For example, PKC&#x3b4; is both a downstream effector of KRAS (<xref ref-type="bibr" rid="B74">Symonds et al., 2011</xref>) and KRAS can itself be regulated by PKC phosphorylation (<xref ref-type="bibr" rid="B12">Bivona et al., 2006</xref>). KRAP (a regulator of KRAS) is proposed to be a binding partner of IP<sub>3</sub>Rs (<xref ref-type="bibr" rid="B77">Thillaiappan et al., 2021</xref>; <xref ref-type="bibr" rid="B80">Vorontsova et al., 2022</xref>) and loss of IP<sub>3</sub>Rs could alter KRAS signaling by this mechanism. Similarly, p53 can both be regulated by ROS and alter levels of antioxidant enzymes (<xref ref-type="bibr" rid="B43">Liu et al., 2008</xref>). Further work is needed to determine the relative importance of the common pathways for the survival of IP<sub>3</sub>R TKO cells.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Analysis of the HeLa RNAseq data set for Wild-type <italic>versus</italic> IP<sub>3</sub>R TKO cells. <bold>(A)</bold>. Distribution of the 310 differentially expressed genes is shown as a volcano plot. The default cut off for FDR was set at 1% and &#x7c;log<sub>2</sub> FC&#x7c; &#x3e;1. The top 30 genes are indicated. <bold>(B)</bold>. Manually curated gene sets for Ca<sup>2&#x2b;</sup> signaling pathways, transcription factors and mitochondrial genes (MitoCarta 3.0) were used to identify hits within the DEG gene list. The significance level of the gene changes measured by FDR is indicated in the inset. Genes in black were upregulated and genes in blue were downregulated. The origin of the curated gene sets are given in &#x201c;Materials and Methods&#x201d;. <bold>(C)</bold>. Bubble plot of KEGG enrichment analysis of DEGs. Top 20 KEGG pathways (<italic>p</italic> &#x2264; 0.05) are presented. <italic>Y</italic>-axis represents pathways; <italic>X</italic>-axis represents rich factor; (rich factor equals the ratio between the DEGs and all annotated genes enriched in the pathway). The color and size of each bubble represent enrichment significance and the number of DEGs enriched in a pathway, respectively.</p>
</caption>
<graphic xlink:href="fcell-12-1473210-g006.tif"/>
</fig>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Common genes or pathways altered in the HEK293 or HeLa data sets. <bold>(A)</bold> Venn diagram showing the common genes between the HEK293 and HeLa data sets with <bold>(B)</bold> listing the 18 common genes. The significance level of the gene changes measured by FDR is indicated in the inset. Genes in black were upregulated and genes in blue were downregulated. <bold>(C, D)</bold> Gene set enrichment analysis (GSEA) was carried out using a Hallmark gene set found in the Molecular Signatures Database (<ext-link ext-link-type="uri" xlink:href="http://www.gsea-msigdb.org/gsea/msigdb/collections.jsp">http://www.gsea-msigdb.org/gsea/msigdb/collections.jsp</ext-link>). The statistical criteria for significance was a nominal p val&#x2009;&#x3c;0.05 and a false discovery rate q-val&#x2009;&#x3c;0.25.The top 20 enriched or de-enriched categories in the TKO cells based on normalized enrichment score (NES) are shown. Pathways in both data sets that were unique (black), common (red), or common but changing in opposite directions (green) were colored as indicated.</p>
</caption>
<graphic xlink:href="fcell-12-1473210-g007.tif"/>
</fig>
</sec>
<sec id="s3-7">
<title>3.7 Target genes of calcium-regulated transcription factors</title>
<p>Our focus in this study was on transcriptional changes that may result from the loss of Ca<sup>2&#x2b;</sup> signaling in the IP<sub>3</sub>R TKO cells. In particular, we have concentrated on the known Ca<sup>2&#x2b;</sup> dependent transcription factors, e.g., NFAT, CREB, AP-1 and NF&#x3ba;b. Therefore, we wanted to know the contribution of target genes of these transcription factors to the RNAseq data sets. To do this we employed a publicly available transcription factor target gene data base (Harmonizome (<xref ref-type="bibr" rid="B67">Rouillard et al., 2016</xref>)). Of the 828 DEGs in HEK293 cells, 135 genes (16.3%) were NFAT2 targets, 26 (3.1%) were CREB targets, 587 (70.1%) were AP-1 targets and 96 (11.6%) were NF-kB targets. For the 310 DEGs in HeLa cells we identified 47 genes (15.2%) as NFAT2 targets, 6 genes (1.9%) as CREB targets, 207 (66.7%) as AP-1 targets and 33 genes (10.6%) as NF-kB targets. Thus, AP-1 and NFAT were the most affected of the three transcription factors measured in TKO cells. Despite the differences in overall number of DEGs between HEK293 and HeLa cells, the percentage of altered NFAT, CREB, AP-1 and NF&#x3ba;B target genes were similar in both cell lines. It is important to emphasize that the RNAseq data set were obtained from unstimulated cells. NFAT and AP-1 family members can bind cooperatively to adjacent promoter sites and PKC is a known activator of AP-1 (<xref ref-type="bibr" rid="B31">Karin et al., 1997</xref>). This raises the possibility that, although the absence of Ca<sup>2&#x2b;</sup> signaling in TKO cells may impair the activation of NFAT, the higher basal activity of NFAT, together with the activation of Ca<sup>2&#x2b;</sup> -independent PKC isoforms may be sufficient to allow agonists to turn on NFAT target genes. The redundancy of transcription factor activation makes it difficult to test this hypothesis with target genes that are exclusively NFAT responsive. RT-qPCR measurements were made of two representative NFAT target genes (COX2 (<xref ref-type="bibr" rid="B59">Pont et al., 2012</xref>), IRS2 (<xref ref-type="bibr" rid="B17">Demozay et al., 2011</xref>)) and ETS1, which is a transcription factor that interacts with NFAT (<xref ref-type="bibr" rid="B53">Naito et al., 1998</xref>; <xref ref-type="bibr" rid="B78">Tsao et al., 2013</xref>). None of the selected genes showed agonist-mediated increases over a 6&#xa0;h period in HEK293 or HeLa cells (<xref ref-type="sec" rid="s11">Supplementary Figure S5</xref>). PMA stimulated the expression of COX2 and ETS1 in both WT HEK293 and HeLa cells (<xref ref-type="sec" rid="s11">Supplementary Figures S5A&#x2013;D</xref>). The PMA response of COX2 was further increased in TKO cells in both cell lines, but for ETS1 was increased only in HeLa TKO cells. Baseline IRS2 mRNA levels were strongly suppressed in HEK293 TKO cells and to a lesser extent in HeLa TKO cells. This confirms findings from RNAseq data (<xref ref-type="fig" rid="F5">Figure 5</xref>). Previous microarray studies on clones of HEK293 cells with high and low store-operated Ca<sup>2&#x2b;</sup> entry (SOCE) identified IRS2 as a putative regulator of SOCE (<xref ref-type="bibr" rid="B88">Zagranichnaya et al., 2005</xref>), but a mechanistic and functional link between loss of IP<sub>3</sub>R-mediated Ca<sup>2&#x2b;</sup> fluxes and IRS2 remains to be established.</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>Calcium signaling regulates many critical biological processes. This includes the activity of multiple transcription factors, some of which have been shown to be tuned to specific frequencies of Ca<sup>2&#x2b;</sup> oscillations (<xref ref-type="bibr" rid="B19">Dolmetsch et al., 1998</xref>; <xref ref-type="bibr" rid="B42">Li et al., 1998</xref>). In the present study we have examined the behavior of key Ca<sup>2&#x2b;</sup>-dependent transcription factors in the setting of a complete loss of IP<sub>3</sub>-linked Ca<sup>2&#x2b;</sup> signaling using two human cancer cell lines that have been genetically deleted of all three IP<sub>3</sub>R isoforms. The main findings of this study are that chronic loss of IP<sub>3</sub>R-mediated Ca<sup>2&#x2b;</sup> signaling shows the following adaptations in TKO cells: a) an elevated baseline activity of several transcription factors (e.g., NFAT, CREB, AP-1); b) a loss of agonist-mediated activation of NFAT, but not of other transcription factors (e.g., CREB); c) an increased reliance on the Ca<sup>2&#x2b;</sup>-insensitive forms of PKC for maintaining downstream signaling and d) an altered handling of ROS.</p>
<p>Our studies confirm earlier reports that TKO cells have defective agonist-mediated NFAT activation in chicken DT40 cells (<xref ref-type="bibr" rid="B73">Sugawara et al., 1997</xref>), mouse&#xa0;B-lymphocytes (<xref ref-type="bibr" rid="B75">Tang et al., 2017</xref>) and mouse embryonic stem cells (<xref ref-type="bibr" rid="B81">Wang et al., 2017</xref>). The two new findings made in the present study are an elevated baseline NFAT activity in both HEK293 and HeLa TKO cells, and an enhanced sensitivity of NFAT to pharmacological elevation of cytosolic Ca<sup>2&#x2b;</sup>, observed in HEK293 but not in HeLa TKO cells. There is no evidence to suggest that baseline levels of cytosolic Ca<sup>2&#x2b;</sup> or ionophore-mediated Ca<sup>2&#x2b;</sup> release are any different in TKO cells (<xref ref-type="bibr" rid="B87">Yue et al., 2020</xref>; <xref ref-type="bibr" rid="B86">Young et al., 2022</xref>). Therefore, it is more likely that the Ca<sup>2&#x2b;</sup> sensitivity of the CaN/NFAT signaling pathway to baseline and elevated Ca<sup>2&#x2b;</sup> is enhanced in HEK293 TKO cells. A possible molecular mechanism may involve decreased levels of RCAN1, an endogenous inhibitor of CaN (<xref ref-type="fig" rid="F1">Figure 1D</xref>). RCAN1 levels and ionophore sensitivity were unchanged in HeLa TKO cells, suggesting that the mechanism of baseline elevation of NFAT activity in HeLa cells is likely to be different from HEK293 cells and may be related to the different complement of NFAT isoforms in the 2&#xa0;cell lines (<xref ref-type="bibr" rid="B8">Bekker-Jensen et al., 2017</xref>).</p>
<p>We also found increased baseline activity of CREB in both HEK293 and HeLa TKO cells, but again only the HEK293 TKO cells showed an enhanced response to ionophore that was suppressed by CsA (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Like NFAT, CREB activation is also linked to CaN, independently of ser133 phosphorylation, since the nuclear translocation of the CREB co-activator CRTC1-3 requires dephosphorylation by CaN (<xref ref-type="bibr" rid="B68">Screaton et al., 2004</xref>). The upstream kinase regulation of CRTC&#x2019;s is different in HeLa cells (<xref ref-type="bibr" rid="B32">Katoh et al., 2006</xref>) and therefore the different sensitivity of CREB to ionophore in the two TKO cell lines is not unexpected. Agonist-induced increases of CREB ser-133 phosphorylation is maintained in both TKO cell lines, and our studies with PKC inhibitors and siRNA suggests that this is mediated in part by the Ca<sup>2&#x2b;</sup> insensitive PKC&#x3b4; isoform. An increased reliance on Ca<sup>2&#x2b;</sup>-insensitive PKC isoforms may be an important adaptive mechanism maintaining down-stream signaling in the absence of Ca<sup>2&#x2b;</sup> changes in agonist-stimulated TKO cells. In WT cells with a Ca<sup>2&#x2b;</sup> signal, competition for membrane-bound DAG favors the translocation of classical rather than the novel PKC isoforms (<xref ref-type="bibr" rid="B41">Lenz et al., 2002</xref>). When the Ca<sup>2&#x2b;</sup> signals are eliminated with BAPTA loading, only the novel PKC isoforms show translocation (<xref ref-type="bibr" rid="B41">Lenz et al., 2002</xref>). Thus, the increased reliance on the novel PKC isoforms in TKO cells may reflect the outcome of this competition without necessarily involving altered DAG levels or additional regulatory mechanisms.</p>
<p>Another transcription factor that showed increased baseline promoter activity in TKO cells was AP-1 and this was associated with elevated protein levels of some members of the fos and jun family members (e.g., c-jun in HEK293 cells). The rapid induction of c-fos by elevated Ca<sup>2&#x2b;</sup> is a well documented effect in many cell types (<xref ref-type="bibr" rid="B64">Roche and Prentki, 1994</xref>), but in the human cancer cell lines studied here, c-fos was already constitutively expressed under basal conditions and showed only small increases with agonist in WT and TKO cells. However, in WT HEK293 cells fosB was absent under baseline conditions and was markedly induced by agonist only in WT and not TKO cells. This suggests that fosB induction may also require NFAT activation. Studies in cultured monocytes have shown that induction of fosB is dependent on NFAT4 activation (<xref ref-type="bibr" rid="B36">Kotla et al., 2017</xref>). Since dimeric members of the fos family have no transcriptional activity by themselves, they must bind with other partners, which include NFATs (<xref ref-type="bibr" rid="B36">Kotla et al., 2017</xref>). Further studies are required to determine the transcriptional consequences of the loss of fosB induction in HEK293 TKO cells.</p>
<p>Increased production of ROS may contribute to the baseline elevation of many of the transcription factors examined in the present study (<xref ref-type="bibr" rid="B1">Abate et al., 1990</xref>; <xref ref-type="bibr" rid="B27">Ichiki et al., 2003</xref>; <xref ref-type="bibr" rid="B51">Morgan and Liu, 2011</xref>; <xref ref-type="bibr" rid="B79">Vaeth and Feske, 2018</xref>; <xref ref-type="bibr" rid="B3">Aggarwal et al., 2019</xref>; <xref ref-type="bibr" rid="B58">Peng et al., 2021</xref>). Our main observations on ROS were that H<sub>2</sub>O<sub>2</sub> production was increased and superoxide production was decreased in both TKO cell lines, consistent with enhanced dismutation by increased SOD enzyme concentrations (<xref ref-type="fig" rid="F4">Figures 4E,F</xref>). It is important to stress that the TKO cells are not undergoing &#x2018;oxidative stress&#x2019;, since the cytosolic glutathione pool was actually more reduced than WT cells (<xref ref-type="sec" rid="s11">Supplementary Figure S4B</xref>). The differences appear unrelated to the total NADP<sup>&#x2b;</sup>/NADPH ratio since this was not significantly changed in TKO cells (<xref ref-type="bibr" rid="B86">Young et al., 2022</xref>). Our data suggest that redox balance is maintained, in part, because the increased production of ROS is accompanied by increased expression of antioxidant enzymes, including catalase and superoxide dismutase, suggesting that increasing H<sub>2</sub>O<sub>2</sub> for signaling purposes may be an important adaptation in the absence of ER Ca<sup>2&#x2b;</sup> signaling. The transcription of these enzymes are regulated by the redox-sensitive transcription factor Nrf2 (<xref ref-type="bibr" rid="B45">Ma, 2013</xref>), which also shows increased activity in TKO cells (<xref ref-type="fig" rid="F4">Figure 4I</xref>). Inhibitor studies point to the possible involvement of an NADPH oxidase isoform, but further work is required to establish the exact source(s) of increased ROS in TKO cells. A previous study in DT40 TKO cells also concluded that ROS production was increased and that the total glutathione pool was more reduced, but the results differed in that SOD2 was decreased and catalase was unchanged (<xref ref-type="bibr" rid="B82">Wen et al., 2015</xref>).A complex relationship is expected between a higher basal activity of Ca<sup>2&#x2b;</sup>-dependent transcription factors and their target genes since this would depend on the magnitude of the basal increase and the fact that target genes can be activated by a network of multiple transcriptional activators/repressors. Indeed, analysis of the basal RNAseq data shows that many of the predicted target genes for Ca<sup>2&#x2b;</sup> dependent transcription factors actually decrease in TKO cells. For example, only 54% and 49% of known NFAT2 target genes were significantly upregulated in the DEG list of HEK293 and HeLa TKO cells respectively. The maintenance of a higher basal activity of transcription factors may also have functional consequences for agonist-mediated changes. In wild-type cells the concerted effects of both Ca<sup>2&#x2b;</sup> and DAG signals allow the cells to transition from a resting to a stimulated state (<xref ref-type="bibr" rid="B13">Brignall et al., 2017</xref>) (<xref ref-type="fig" rid="F8">Figure 8</xref>). We hypothesize that the maintenance of a higher basal activity in TKO cells may be a mechanism to allow some signaling pathways to be fully activated by the DAG signal alone. Further work is necessary to validate this hypothesis.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Hypothetical scheme showing agonist-mediated activation of signaling in WT and TKO cells In WT cells both Ca<sup>2&#x2b;</sup> mobilization and DAG formation mediate the transition of signaling pathways from &#x2018;resting&#x2019; to an &#x2018;activated&#x2019; state. In TKO cells many signaling pathways have adapted by adjusting their Ca<sup>2&#x2b;</sup> sensitivity to be active at resting Ca<sup>2&#x2b;</sup> (e.g., NFAT), increasing their reliance on the DAG signal alone (e.g., CREB via PKC&#x3b4;) and becoming sensitized to increased ROS (e.g., Jnk, AP-1).</p>
</caption>
<graphic xlink:href="fcell-12-1473210-g008.tif"/>
</fig>
<p>Several limitations of this study can be identified. Although the RNAseq studies did identify common pathways changed in both IP<sub>3</sub>R TKO models, we did not come to a conclusion on which specific genes and which specific pathways play a central role in survival without Ca<sup>2&#x2b;</sup> signaling. The RNAseq data set was obtained from TKO cells at baseline. Obtaining data from agonist-stimulated cells and using alternative approaches, such as a global CRISPR screen, may provide valuable information. The use of alternative NFAT promoters (e.g., IL-8 (<xref ref-type="bibr" rid="B89">Zhang et al., 2018</xref>)) which respond to Ca<sup>2&#x2b;</sup> alone, independently of PKC, may prove useful to examine altered regulation of NFAT in TKO cells. Many differences in the behavior of HEK293 and HeLa TKO cells are observed in our study suggesting that adaptive mechanisms may not be generally applicable to all model systems in which Ca<sup>2&#x2b;</sup> signaling has been ablated. The study did not specifically identify the molecular link between the loss of IP<sub>3</sub>Rs and increased ROS levels although we have suggested that increased expression/activity of an NADPH oxidase isoform may be involved.</p>
<p>Our studies challenge the widely held belief that Ca<sup>2&#x2b;</sup> signaling is essential for cell function and suggest that this may not be valid under all conditions. Deletions in IP<sub>3</sub>Rs are lethal when this occurs in tissues where only one IP<sub>3</sub>R isoform predominates (e.g., IP<sub>3</sub>R1 in brain), or in organisms expressing only one isoform (e.g., <italic>Drosophila</italic>) (<xref ref-type="bibr" rid="B24">Hasan, 2013</xref>). However, where all 3 IP<sub>3</sub>R isoforms are present initially and are sequentially deleted, the conditions may be more favorable for the development of adaptive mechanisms to tolerate the loss of Ca<sup>2&#x2b;</sup> signaling. The ability of TKO human cancer cell lines to grow and divide in the absence of any Ca<sup>2&#x2b;</sup> signaling can probably be attributed to the maintained activity/redundancy of important signaling pathways (e.g., CREB, MAPK, etc.) required for growth. However, the finding that some TKO cells grow more slowly is an indication that there are Ca<sup>2&#x2b;</sup> regulatory step(s) that cannot be completely circumvented by adaptive mechanisms. Modulation of IP<sub>3</sub>R function is a therapeutic strategy that may be beneficial in the treatment of several diseases (<xref ref-type="bibr" rid="B14">Bruce and James, 2020</xref>; <xref ref-type="bibr" rid="B28">Ismatullah et al., 2024</xref>; <xref ref-type="bibr" rid="B69">Smith-Cortinez et al., 2024</xref>). Understanding the molecular basis of adaptive mechanisms resulting from loss of IP<sub>3</sub>R function may provide valuable insights into how cells can bypass the need for Ca<sup>2&#x2b;</sup> signaling and to predict the consequences of blocking IP<sub>3</sub>R function with drugs or in genetic diseases linked to IP<sub>3</sub>R dysfunction.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are publicly available. This data can be found here: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283304">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc&#x003D;GSE283304</ext-link>.</p>
</sec>
<sec sec-type="ethics-statement" id="s6">
<title>Ethics statement</title>
<p>Ethical approval was not required for the studies on humans or animals in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.</p>
</sec>
<sec sec-type="author-contributions" id="s7">
<title>Author contributions</title>
<p>MY: Formal Analysis, Investigation, Writing&#x2013;original draft, Writing&#x2013;review and editing. DB: Formal Analysis, Investigation, Writing&#x2013;original draft, Writing&#x2013;review and editing. DS: Formal Analysis, Writing&#x2013;original draft, Writing&#x2013;review and editing. MT: Formal Analysis, Funding acquisition, Writing&#x2013;original draft, Writing&#x2013;review and editing. GH: Conceptualization, Funding acquisition, Supervision, Writing&#x2013;original draft, Writing&#x2013;review and editing. SJ: Conceptualization, Formal Analysis, Funding acquisition, Project administration, Writing&#x2013;original draft, Writing&#x2013;review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by NIH RO1 grants GM132611 (SJ), GM151536 (GH) and 5R35GM147191 (MT). MPY and DB were supported by an NIH NIAAA training grant T32- AA007463.</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcell.2024.1473210/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcell.2024.1473210/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material>
<label>SUPPLEMENTARY FIGURE S1</label>
<caption>
<p>Rescue of elevated baseline of NFAT, CREB and AP-1 by IP<sub>3</sub>R1. Basal levels of the luciferase reporter activities of NFAT, CREB and AP-1 luciferase reporters were determined in HEK293 WT, TKO or a stable rescue TKO cell line containing the human type-I IP<sub>3</sub>R. The data were corrected for transfection efficiency with Renilla luciferase and are expressed as fold activation relative to the baseline in WT cells. The data are from two independent experiments carried out in triplicate. Statistical analysis are from unpaired t-test comparisons to the WT baseline. &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x2264; 0.0001, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x2264; 0.001, &#x2a;&#x2a;<italic>p</italic> &#x2264; 0.01, &#x2a;<italic>p</italic> &#x2264; 0.05, NS not significant.</p>
</caption>
</supplementary-material>
<supplementary-material>
<label>SUPPLEMENTARY FIGURE S2</label>
<caption>
<p>Fos and Jun protein changes in HeLa TKO cells. Lysates were prepared from HeLa WT and TKO cells treated with 100&#xb5;M Histamine (His) for 4&#xa0;h. Samples were immunoblotted for the indicated AP-1 family members and quantitated using GAPDH as a loading control. Data were normalized to the WT unstimulated values. <bold>(A)</bold> c-fos; <bold>(B)</bold> c-jun; <bold>(C)</bold> junB; <bold>(D)</bold> GAPDH. The data shown are the mean &#xb1; S.E.M.of 3 independent experiments. All data are statistically significant from WT unstimulated values at <italic>p</italic> &#x2264; 0.05 with only the data not significantly different marked &#x201c;ns&#x201d;.</p>
</caption>
</supplementary-material>
<supplementary-material>
<label>SUPPLEMENTARY FIGURE S3</label>
<caption>
<p>Jnk and ERK1/2 changes in HEK293 TKO cells. <bold>(A)</bold> shows immunoblots of p-Jnk and total Jnk in WT and TKO HEK293 cells. The baseline <bold>(B)</bold> and stimulation by 1mM carbachol (Cch) is quantitated for the p54 isoform of Jnk in 3 independent experiments <bold>(C, D)</bold> shows immunoblots of p-ERK1/2 (p42/p44), total ERK and Grb2 (used as a loading control). Quantitation of the data is shown in <bold>(E)</bold>. HEK293 <bold>(F)</bold> and HeLa <bold>(G)</bold> were cotransfected with the NFkb luciferase reporter and Renilla luciferase constructs. Treatment conditions were as described for <xref ref-type="fig" rid="F1">Figure 1</xref>.</p>
</caption>
</supplementary-material>
<supplementary-material>
<label>SUPPLEMENTARY FIGURE S4</label>
<caption>
<p>Glutathione levels and glutathione peroxidase activity in HEK293 TKO cells. <bold>(A)</bold> shows an assay of glutathione peroxidase activity in Units per liter per mg protein (GPx U/l/mg) in lysates derived from WT (black) and TKO (red) HEK293 (left) and HeLa (right) cells as detailed in Experimental procedures. &#x2a; Represents <italic>p</italic> &#x2264; 0.05, data points represent individual technical replicates. <bold>(B)</bold> Shows the oxidized to reduced glutathione (OxyD; GSH:GSSG) measured with Grx1roGFP2 targeted to the cytosol (left) or mitochondrial matrix under basal or agonist simulated conditions (Charbachol, CCh 1mM 10 minutes). &#x2a;&#x2a;,&#x2a;&#x2a;&#x2a; &#x26; &#x2a;&#x2a;&#x2a;&#x2a; represent <italic>p</italic> &#x2264; 0.05,0.01 &#x26; 0.001 respectively in a Kruskal Wallis test. <bold>(C)</bold> The concentration of intracellular H<sub>2</sub>O<sub>2</sub> was measured with HyPer7 targeted to the cytosol transiently transfected into HEK293 WT and TKO cells growing in 96well plates as described in &#x201c;Experimental Procedures&#x201d;. Cells were treated with Antimycin A (AA; 0.5&#xa0;&#x3bc;M), and N-acetyl cysteine (NAC; 1mM) as positive and negative controls respectively. Data presented as (R-Rmin)/(Rmax-Rmin). Statistics as in <bold>(A, B)</bold>.</p>
</caption>
</supplementary-material>
<supplementary-material>
<label>SUPPLEMENTARY FIGURE S5</label>
<caption>
<p>RT-qPCR and target genes of transcription factors in HEK293 and HeLa TKO cells. RT-qPCR was performed using the primers for COX2, ETS1 and IRS2 genes as described in &#x2018;Experimental Procedures&#x2019;. The experiments were done on HEK293 <bold>(A, C, E)</bold> or HeLa <bold>(B, D, F)</bold> stimulated for 6h with agonist (carbachol (Cch) 1mM; histamine (His) 100&#xa0;uM) or PMA (100&#xa0;nM). Relative expression levels of target genes were analyzed by the 2 <sup>&#x2013;&#x394;&#x394;Ct</sup> method using either actin or GAPDH as a housekeeping gene. Data are expressed as fold-change compared to the untreated WT control. Each experiment was performed twice using three technical replicates. Data was expressed as the mean &#xb1; SD and significance between WT and TKO cells was assessed by Student&#x2019;s t-test.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Image3.tif" id="SM1" mimetype="application/tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image4.tif" id="SM2" mimetype="application/tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image2.tif" id="SM3" mimetype="application/tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image1.tif" id="SM4" mimetype="application/tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image5.tif" id="SM5" mimetype="application/tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<sec id="s12">
<title>Abbreviations</title>
<p>[Ca<sup>2&#x2b;</sup>]<sub>c</sub>, cytosolic [Ca<sup>2&#x2b;</sup>]; CaN, Calcineurin; PKC, protein kinase C; ETC, electron transport chain; COX2, cyclooxygenase-2; ETS1, E26 transformation specific sequence-1; IRS-2, insulin receptor substrate-2; NFAT, nuclear factor of activated T-cells; CREB, cAMP response element-binding protein; AP1, activator protein-1; NF&#x3ba;b, Nuclear factor kappa-light-chain-enhancer of activated B cells; FDR, false discovery rate.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abate</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rauscher</surname>
<given-names>F. J.</given-names>
</name>
<name>
<surname>Curran</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Redox regulation of fos and jun DNA-binding activity <italic>in vitro</italic>
</article-title>. <source>Science</source> <volume>249</volume> (<issue>4973</issue>), <fpage>1157</fpage>&#x2013;<lpage>1161</lpage>. <pub-id pub-id-type="doi">10.1126/science.2118682</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agell</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bachs</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Rocamora</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Villalonga</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Modulation of the Ras/Raf/MEK/ERK pathway by Ca(2&#x2b;), and calmodulin</article-title>. <source>Cell. Signal</source> <volume>14</volume> (<issue>8</issue>), <fpage>649</fpage>&#x2013;<lpage>654</lpage>. <pub-id pub-id-type="doi">10.1016/s0898-6568(02)00007-4</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aggarwal</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Tuli</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Varol</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Thakral</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yerer</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Sak</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements</article-title>. <source>Biomolecules</source> <volume>9</volume> (<issue>11</issue>), <fpage>735</fpage>. <pub-id pub-id-type="doi">10.3390/biom9110735</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alzayady</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chandrasekhar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Van Petegem</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yule</surname>
<given-names>D. I.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Defining the stoichiometry of inositol 1,4,5-trisphosphate binding required to initiate Ca2&#x2b; release</article-title>. <source>Sci. Signal</source> <volume>9</volume>, <fpage>ra35</fpage>(<issue>422)</issue>. <pub-id pub-id-type="doi">10.1126/scisignal.aad6281</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ando</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hirose</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mikoshiba</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Aberrant IP3 receptor activities revealed by comprehensive analysis of pathological mutations causing spinocerebellar ataxia 29</article-title>. <source>Proc. Natl. Acad. Sci. U S A.</source> <volume>115</volume> (<issue>48</issue>), <fpage>12259</fpage>&#x2013;<lpage>12264</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1811129115</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arguin</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Caron</surname>
<given-names>A. Z.</given-names>
</name>
<name>
<surname>Elkoreh</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Denault</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Guillemette</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>The transcription factors NFAT and CREB have different susceptibilities to the reduced Ca2&#x2b; responses caused by the knock down of inositol trisphosphate receptor in HEK 293A cells</article-title>. <source>Cell. Physiol. Biochem.</source> <volume>26</volume> (<issue>4-5</issue>), <fpage>629</fpage>&#x2013;<lpage>640</lpage>. <pub-id pub-id-type="doi">10.1159/000322330</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arige</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Terry</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Malik</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Functional determination of calcium-binding sites required for the activation of inositol 1,4,5-trisphosphate receptors</article-title>. <source>Proc. Natl. Acad. Sci. U S A.</source> <volume>119</volume> (<issue>39</issue>), <fpage>e2209267119</fpage>. <pub-id pub-id-type="doi">10.1073/pnas.2209267119</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bekker-Jensen</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Kelstrup</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Batth</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Haldrup</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bramsen</surname>
<given-names>J. B.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>An optimized shotgun strategy for the rapid generation of comprehensive human proteomes</article-title>. <source>Cell. Syst.</source> <volume>4</volume> (<issue>6</issue>), <fpage>587</fpage>&#x2013;<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1016/j.cels.2017.05.009</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berridge</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Bootman</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Roderick</surname>
<given-names>H. L.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Calcium signalling: dynamics, homeostasis and remodelling</article-title>. <source>Nat. Rev. Mol. Cell. Biol.</source> <volume>4</volume> (<issue>7</issue>), <fpage>517</fpage>&#x2013;<lpage>529</lpage>. <pub-id pub-id-type="doi">10.1038/nrm1155</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berry</surname>
<given-names>C. T.</given-names>
</name>
<name>
<surname>May</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Freedman</surname>
<given-names>B. D.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>STIM- and Orai-mediated calcium entry controls NF-&#x3ba;B activity and function in lymphocytes</article-title>. <source>Cell. Calcium</source> <volume>74</volume>, <fpage>131</fpage>&#x2013;<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2018.07.003</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bittremieux</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gerasimenko</surname>
<given-names>J. V.</given-names>
</name>
<name>
<surname>Schuermans</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Luyten</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Stapleton</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Alzayady</surname>
<given-names>K. J.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>DPB162-AE, an inhibitor of store-operated Ca(2&#x2b;) entry, can deplete the endoplasmic reticulum Ca(2&#x2b;) store</article-title>. <source>Cell. Calcium</source> <volume>62</volume>, <fpage>60</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2017.01.015</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bivona</surname>
<given-names>T. G.</given-names>
</name>
<name>
<surname>Quatela</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Bodemann</surname>
<given-names>B. O.</given-names>
</name>
<name>
<surname>Ahearn</surname>
<given-names>I. M.</given-names>
</name>
<name>
<surname>Soskis</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Mor</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis</article-title>. <source>Mol. Cell.</source> <volume>21</volume> (<issue>4</issue>), <fpage>481</fpage>&#x2013;<lpage>493</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2006.01.012</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brignall</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cauchy</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bevington</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Gorman</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Pisco</surname>
<given-names>A. O.</given-names>
</name>
<name>
<surname>Bagnall</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Integration of kinase and calcium signaling at the level of chromatin underlies inducible gene activation in T cells</article-title>. <source>J. Immunol.</source> <volume>199</volume> (<issue>8</issue>), <fpage>2652</fpage>&#x2013;<lpage>2667</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1602033</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bruce</surname>
<given-names>J. I. E.</given-names>
</name>
<name>
<surname>James</surname>
<given-names>A. D.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Targeting the calcium signalling machinery in cancer</article-title>. <source>Cancers (Basel)</source> <volume>12</volume> (<issue>9</issue>), <fpage>2351</fpage>. <pub-id pub-id-type="doi">10.3390/cancers12092351</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakraborty</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Deb</surname>
<given-names>B. K.</given-names>
</name>
<name>
<surname>Arige</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Musthafa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Malik</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yule</surname>
<given-names>D. I.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Regulation of store-operated Ca(2&#x2b;) entry by IP(3) receptors independent of their ability to release Ca(2)</article-title>. <source>Elife</source> <volume>12</volume>, <fpage>e80447</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.80447</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chao</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Rapp</surname>
<given-names>U. R.</given-names>
</name>
<name>
<surname>Rosner</surname>
<given-names>M. R.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Differential Raf requirement for activation of mitogen-activated protein kinase by growth factors, phorbol esters, and calcium</article-title>. <source>J. Biol. Chem.</source> <volume>269</volume> (<issue>10</issue>), <fpage>7337</fpage>&#x2013;<lpage>7341</lpage>. <pub-id pub-id-type="doi">10.1016/s0021-9258(17)37289-7</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Demozay</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tsunekawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Briaud</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rhodes</surname>
<given-names>C. J.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Specific glucose-induced control of insulin receptor substrate-2 expression is mediated via Ca2&#x2b;-dependent calcineurin/NFAT signaling in primary pancreatic islet &#x3b2;-cells</article-title>. <source>Diabetes</source> <volume>60</volume> (<issue>11</issue>), <fpage>2892</fpage>&#x2013;<lpage>2902</lpage>. <pub-id pub-id-type="doi">10.2337/db11-0341</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dewenter</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>von der Lieth</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Katus</surname>
<given-names>H. A.</given-names>
</name>
<name>
<surname>Backs</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Calcium signaling and transcriptional regulation in cardiomyocytes</article-title>. <source>Circ. Res.</source> <volume>121</volume> (<issue>8</issue>), <fpage>1000</fpage>&#x2013;<lpage>1020</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.310355</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dolmetsch</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>R. S.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Calcium oscillations increase the efficiency and specificity of gene expression</article-title>. <source>Nature</source> <volume>392</volume> (<issue>6679</issue>), <fpage>933</fpage>&#x2013;<lpage>936</lpage>. <pub-id pub-id-type="doi">10.1038/31960</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Enslen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tokumitsu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Stork</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Soderling</surname>
<given-names>T. R.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade</article-title>. <source>Proc. Natl. Acad. Sci. U S A.</source> <volume>93</volume> (<issue>20</issue>), <fpage>10803</fpage>&#x2013;<lpage>10808</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.93.20.10803</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greenberg</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Ziff</surname>
<given-names>E. B.</given-names>
</name>
</person-group> (<year>1984</year>). <article-title>Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene</article-title>. <source>Nature</source> <volume>311</volume> (<issue>5985</issue>), <fpage>433</fpage>&#x2013;<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1038/311433a0</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greenberg</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Ziff</surname>
<given-names>E. B.</given-names>
</name>
<name>
<surname>Greene</surname>
<given-names>L. A.</given-names>
</name>
</person-group> (<year>1986</year>). <article-title>Stimulation of neuronal acetylcholine receptors induces rapid gene transcription</article-title>. <source>Science</source> <volume>234</volume> (<issue>4772</issue>), <fpage>80</fpage>&#x2013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1126/science.3749894</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gutscher</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pauleau</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Marty</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Brach</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wabnitz</surname>
<given-names>G. H.</given-names>
</name>
<name>
<surname>Samstag</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Real-time imaging of the intracellular glutathione redox potential</article-title>. <source>Nat. Methods</source> <volume>5</volume> (<issue>6</issue>), <fpage>553</fpage>&#x2013;<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.1212</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasan</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Intracellular signaling in neurons: unraveling specificity, compensatory mechanisms and essential gene function</article-title>. <source>Curr. Opin. Neurobiol.</source> <volume>23</volume> (<issue>1</issue>), <fpage>62</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2012.07.004</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hogan</surname>
<given-names>P. G.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Nardone</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Transcriptional regulation by calcium, calcineurin, and NFAT</article-title>. <source>Genes. Dev.</source> <volume>17</volume> (<issue>18</issue>), <fpage>2205</fpage>&#x2013;<lpage>2232</lpage>. <pub-id pub-id-type="doi">10.1101/gad.1102703</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hortenhuber</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Toledo</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Smedler</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Arenas</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Malmersjo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Louhivuori</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Mapping genes for calcium signaling and their associated human genetic disorders</article-title>. <source>Bioinformatics</source> <volume>33</volume> (<issue>16</issue>), <fpage>2547</fpage>&#x2013;<lpage>2554</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btx225</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ichiki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tokunou</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fukuyama</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Iino</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Masuda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Takeshita</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Cyclic AMP response element-binding protein mediates reactive oxygen species-induced c-fos expression</article-title>. <source>Hypertension</source> <volume>42</volume> (<issue>2</issue>), <fpage>177</fpage>&#x2013;<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1161/01.HYP.0000079791.26014.04</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ismatullah</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jabeen</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kiani</surname>
<given-names>Y. S.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Structural and functional insight into a new emerging target IP(3)R in cancer</article-title>. <source>J. Biomol. Struct. Dyn.</source> <volume>42</volume> (<issue>4</issue>), <fpage>2170</fpage>&#x2013;<lpage>2196</lpage>. <pub-id pub-id-type="doi">10.1080/07391102.2023.2201332</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johannessen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Delghandi</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Moens</surname>
<given-names>U.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>What turns CREB on?</article-title> <source>Cell. Signal</source> <volume>16</volume> (<issue>11</issue>), <fpage>1211</fpage>&#x2013;<lpage>1227</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellsig.2004.05.001</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Parekh</surname>
<given-names>A. B.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Distinct spatial Ca2&#x2b; signatures selectively activate different NFAT transcription factor isoforms</article-title>. <source>Mol. Cell.</source> <volume>58</volume> (<issue>2</issue>), <fpage>232</fpage>&#x2013;<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2015.02.027</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zandi</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>AP-1 function and regulation</article-title>. <source>Curr. Opin. Cell. Biol.</source> <volume>9</volume> (<issue>2</issue>), <fpage>240</fpage>&#x2013;<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1016/s0955-0674(97)80068-3</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katoh</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Takemori</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>X. Z.</given-names>
</name>
<name>
<surname>Tamura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Muraoka</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Satoh</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade</article-title>. <source>FEBS J.</source> <volume>273</volume> (<issue>12</issue>), <fpage>2730</fpage>&#x2013;<lpage>2748</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2006.05291.x</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katona</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bartok</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nichtova</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Csordas</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Berezhnaya</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Capture at the ER-mitochondrial contacts licenses IP(3) receptors to stimulate local Ca(2&#x2b;) transfer and oxidative metabolism</article-title>. <source>Nat. Commun.</source> <volume>13</volume> (<issue>1</issue>), <fpage>6779</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-022-34365-8</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Na</surname>
<given-names>Y. R.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>E. G.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Protein kinase C isoforms differentially regulate hypoxia-inducible factor-1&#x3b1; accumulation in cancer cells</article-title>. <source>J. Cell. Biochem.</source> <volume>117</volume> (<issue>3</issue>), <fpage>647</fpage>&#x2013;<lpage>658</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.25314</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Koyanagi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mochly-Rosen</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>PKC&#x3b4; activation mediates angiogenesis via NADPH oxidase activity in PC-3 prostate cancer cells</article-title>. <source>Prostate</source> <volume>71</volume> (<issue>9</issue>), <fpage>946</fpage>&#x2013;<lpage>954</lpage>. <pub-id pub-id-type="doi">10.1002/pros.21310</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kotla</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>N. K.</given-names>
</name>
<name>
<surname>Kirchhofer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>G. N.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Heterodimers of the transcriptional factors NFATc3 and FosB mediate tissue factor expression for 15(S)-hydroxyeicosatetraenoic acid-induced monocyte trafficking</article-title>. <source>J. Biol. Chem.</source> <volume>292</volume> (<issue>36</issue>), <fpage>14885</fpage>&#x2013;<lpage>14901</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M117.804344</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kupzig</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Cullen</surname>
<given-names>P. J.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>The frequencies of calcium oscillations are optimized for efficient calcium-mediated activation of Ras and the ERK/MAPK cascade</article-title>. <source>Proc. Natl. Acad. Sci. U S A.</source> <volume>102</volume> (<issue>21</issue>), <fpage>7577</fpage>&#x2013;<lpage>7582</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0409611102</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuwahara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>McAnally</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Bassel-Duby</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>J. A.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling</article-title>. <source>J. Clin. Investig.</source> <volume>116</volume> (<issue>12</issue>), <fpage>3114</fpage>&#x2013;<lpage>3126</lpage>. <pub-id pub-id-type="doi">10.1172/JCI27702</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lagos-Cabre</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ivanova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>C. W.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Ca(2&#x2b;) release by IP(3) receptors is required to orient the mitotic spindle</article-title>. <source>Cell. Rep.</source> <volume>33</volume> (<issue>11</issue>), <fpage>108483</fpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2020.108483</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lambert</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Jolma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Campitelli</surname>
<given-names>L. F.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>P. K.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Albu</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>The human transcription factors</article-title>. <source>Cell.</source> <volume>172</volume> (<issue>4</issue>), <fpage>650</fpage>&#x2013;<lpage>665</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.01.029</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lenz</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Reusch</surname>
<given-names>H. P.</given-names>
</name>
<name>
<surname>Albrecht</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Schultz</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schaefer</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Ca2&#x2b;-controlled competitive diacylglycerol binding of protein kinase C isoenzymes in living cells</article-title>. <source>J.Cell Biol.</source> <volume>159</volume> (<issue>2</issue>), <fpage>291</fpage>&#x2013;<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200203048</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Llopis</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Whitney</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zlokarnik</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tsien</surname>
<given-names>R. Y.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Cell-permeant caged InsP3 ester shows that Ca2&#x2b; spike frequency can optimize gene expression</article-title>. <source>Nature</source> <volume>392</volume> (<issue>6679</issue>), <fpage>936</fpage>&#x2013;<lpage>941</lpage>. <pub-id pub-id-type="doi">10.1038/31965</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>St Clair</surname>
<given-names>D. K.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>ROS and p53: a versatile partnership</article-title>. <source>Free Radic. Biol. Med.</source> <volume>44</volume> (<issue>8</issue>), <fpage>1529</fpage>&#x2013;<lpage>1535</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2008.01.011</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Busillo</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Benovic</surname>
<given-names>J. L.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>M3 muscarinic acetylcholine receptor-mediated signaling is regulated by distinct mechanisms</article-title>. <source>Mol. Pharmacol.</source> <volume>74</volume> (<issue>2</issue>), <fpage>338</fpage>&#x2013;<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1124/mol.107.044750</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Role of nrf2 in oxidative stress and toxicity</article-title>. <source>Annu. Rev. Pharmacol. Toxicol.</source> <volume>53</volume>, <fpage>401</fpage>&#x2013;<lpage>426</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-pharmtox-011112-140320</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macian</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>NFAT proteins: key regulators of T-cell development and function</article-title>. <source>Nat. Rev. Immunol.</source> <volume>5</volume> (<issue>6</issue>), <fpage>472</fpage>&#x2013;<lpage>484</lpage>. <pub-id pub-id-type="doi">10.1038/nri1632</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macian</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lopez-Rodriguez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Partners in transcription: NFAT and AP-1</article-title>. <source>Oncogene</source> <volume>20</volume> (<issue>19</issue>), <fpage>2476</fpage>&#x2013;<lpage>2489</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1204386</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manea</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Constantin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Manda</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sasson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Manea</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Regulation of Nox enzymes expression in vascular pathophysiology: focusing on transcription factors and epigenetic mechanisms</article-title>. <source>Redox Biol.</source> <volume>5</volume>, <fpage>358</fpage>&#x2013;<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2015.06.012</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masaki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shimada</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Decoding the phosphatase code: regulation of cell proliferation by calcineurin</article-title>. <source>Int. J. Mol. Sci.</source> <volume>23</volume> (<issue>3</issue>), <fpage>1122</fpage>. <pub-id pub-id-type="doi">10.3390/ijms23031122</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mattila</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Ullman</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Fiering</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Emmel</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>McCutcheon</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Crabtree</surname>
<given-names>G. R.</given-names>
</name>
<etal/>
</person-group> (<year>1990</year>). <article-title>The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes</article-title>. <source>EMBO J.</source> <volume>9</volume> (<issue>13</issue>), <fpage>4425</fpage>&#x2013;<lpage>4433</lpage>. <pub-id pub-id-type="doi">10.1002/j.1460-2075.1990.tb07893.x</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z. G.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Crosstalk of reactive oxygen species and NF-&#x3ba;B signaling</article-title>. <source>Cell. Res.</source> <volume>21</volume> (<issue>1</issue>), <fpage>103</fpage>&#x2013;<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2010.178</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murphy</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Bayir</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Belousov</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>K. J. A.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>M. J.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Guidelines for measuring reactive oxygen species and oxidative damage in cells and <italic>in vivo</italic>
</article-title>. <source>Nat. Metab.</source> <volume>4</volume> (<issue>6</issue>), <fpage>651</fpage>&#x2013;<lpage>662</lpage>. <pub-id pub-id-type="doi">10.1038/s42255-022-00591-z</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naito</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fagin</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Ets-1 is an early response gene activated by ET-1 and PDGF-BB in vascular smooth muscle cells</article-title>. <source>Am. J. Physiol.</source> <volume>274</volume> (<issue>2</issue>), <fpage>C472</fpage>&#x2013;<lpage>C480</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.1998.274.2.C472</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakabeppu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nathans</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity</article-title>. <source>Cell.</source> <volume>64</volume> (<issue>4</issue>), <fpage>751</fpage>&#x2013;<lpage>759</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(91)90504-r</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nixon</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Bishop</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bradshaw</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>P. D.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Elliott</surname>
<given-names>L. H.</given-names>
</name>
<etal/>
</person-group> (<year>1992</year>). <article-title>The design and biological properties of potent and selective inhibitors of protein kinase C</article-title>. <source>Biochem. Soc. Trans.</source> <volume>20</volume> (<issue>2</issue>), <fpage>419</fpage>&#x2013;<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1042/bst0200419</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ouyang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Leandro Gomez-Amaro</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Stachura</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Loss of IP3R-dependent Ca2&#x2b; signalling in thymocytes leads to aberrant development and acute lymphoblastic leukemia</article-title>. <source>Nat. Commun.</source> <volume>5</volume>, <fpage>4814</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms5814</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pak</surname>
<given-names>V. V.</given-names>
</name>
<name>
<surname>Ezerina</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lyublinskaya</surname>
<given-names>O. G.</given-names>
</name>
<name>
<surname>Pedre</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Tyurin-Kuzmin</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Mishina</surname>
<given-names>N. M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Ultrasensitive genetically encoded indicator for hydrogen peroxide identifies roles for the oxidant in cell migration and mitochondrial function</article-title>. <source>Cell. Metab.</source> <volume>31</volume> (<issue>3</issue>), <fpage>642</fpage>&#x2013;<lpage>653</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2020.02.003</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Lucavs</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ballard</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Metabolic reprogramming and reactive oxygen species in T cell immunity</article-title>. <source>Front. Immunol.</source> <volume>12</volume>, <fpage>652687</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2021.652687</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pont</surname>
<given-names>J. N.</given-names>
</name>
<name>
<surname>McArdle</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Lopez Bernal</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Oxytocin-stimulated NFAT transcriptional activation in human myometrial cells</article-title>. <source>Mol. Endocrinol.</source> <volume>26</volume> (<issue>10</issue>), <fpage>1743</fpage>&#x2013;<lpage>1756</lpage>. <pub-id pub-id-type="doi">10.1210/me.2012-1057</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quinlan</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Gerencser</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Treberg</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Brand</surname>
<given-names>M. D.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>The mechanism of superoxide production by the antimycin-inhibited mitochondrial Q-cycle</article-title>. <source>J. Biol. Chem.</source> <volume>286</volume> (<issue>36</issue>), <fpage>31361</fpage>&#x2013;<lpage>31372</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.267898</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rath</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ast</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Durham</surname>
<given-names>T. J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations</article-title>. <source>Nucleic Acids Res.</source> <volume>49</volume> (<issue>D1</issue>), <fpage>D1541</fpage>&#x2013;<lpage>D1547</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa1011</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rimessi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rizzuto</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pinton</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Differential recruitment of PKC isoforms in HeLa cells during redox stress</article-title>. <source>Cell. Stress Chaperones</source> <volume>12</volume> (<issue>4</issue>), <fpage>291</fpage>&#x2013;<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1379/csc-211.1</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Smyth</surname>
<given-names>G. K.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title>. <source>Bioinformatics</source> <volume>26</volume> (<issue>1</issue>), <fpage>139</fpage>&#x2013;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roche</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Prentki</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Calcium regulation of immediate-early response genes</article-title>. <source>Cell. Calcium</source> <volume>16</volume> (<issue>4</issue>), <fpage>331</fpage>&#x2013;<lpage>338</lpage>. <pub-id pub-id-type="doi">10.1016/0143-4160(94)90097-3</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ronkko</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Rasila</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Torregrosa-Munumer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pennonen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kvist</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Human IP(3) receptor triple knockout stem cells remain pluripotent despite altered mitochondrial metabolism</article-title>. <source>Cell. Calcium</source> <volume>114</volume>, <fpage>102782</fpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2023.102782</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosen</surname>
<given-names>L. B.</given-names>
</name>
<name>
<surname>Ginty</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>M. E.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras</article-title>. <source>Neuron</source> <volume>12</volume> (<issue>6</issue>), <fpage>1207</fpage>&#x2013;<lpage>1221</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(94)90438-3</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rouillard</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>Gundersen</surname>
<given-names>G. W.</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>N. F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Monteiro</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>McDermott</surname>
<given-names>M. G.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins</article-title>. <source>Database (Oxford)</source> <volume>2016</volume>, <fpage>baw100</fpage>. <pub-id pub-id-type="doi">10.1093/database/baw100</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Screaton</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Conkright</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Katoh</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Best</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Canettieri</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Jeffries</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector</article-title>. <source>Cell.</source> <volume>119</volume> (<issue>1</issue>), <fpage>61</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2004.09.015</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith-Cortinez</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Heegsma</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Podunavac</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zakarian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cardenas</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Faber</surname>
<given-names>K. N.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Novel inositol 1,4,5-trisphosphate receptor inhibitor antagonizes hepatic stellate cell activation: a potential drug to treat liver fibrosis</article-title>. <source>Cells</source> <volume>13</volume> (<issue>9</issue>), <fpage>765</fpage>. <pub-id pub-id-type="doi">10.3390/cells13090765</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srivastava</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Procyk</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Iturrioz</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>P. J.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Phosphorylation is required for PMA- and cell-cycle-induced degradation of protein kinase Cdelta</article-title>. <source>Biochem. J.</source> <volume>368</volume> (<issue>Pt 1</issue>), <fpage>349</fpage>&#x2013;<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20020737</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steven</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Friedrich</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jank</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Heimer</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Budczies</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Denkert</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>What turns CREB on? And off? And why does it matter?</article-title> <source>Cell. Mol. Life Sci.</source> <volume>77</volume> (<issue>20</issue>), <fpage>4049</fpage>&#x2013;<lpage>4067</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-020-03525-8</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramanian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tamayo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mootha</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ebert</surname>
<given-names>B. L.</given-names>
</name>
<name>
<surname>Gillette</surname>
<given-names>M. A.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title>. <source>Proc. Natl. Acad. Sci. U S A.</source> <volume>102</volume> (<issue>43</issue>), <fpage>15545</fpage>&#x2013;<lpage>15550</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sugawara</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kurosaki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takata</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kurosaki</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor</article-title>. <source>EMBO J.</source> <volume>16</volume> (<issue>11</issue>), <fpage>3078</fpage>&#x2013;<lpage>3088</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/16.11.3078</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Symonds</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Ohm</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Heasley</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Boyle</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Franklin</surname>
<given-names>W. A.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Protein kinase C delta is a downstream effector of oncogenic K-ras in lung tumors</article-title>. <source>Cancer Res.</source> <volume>71</volume> (<issue>6</issue>), <fpage>2087</fpage>&#x2013;<lpage>2097</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-10-1511</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Loss of IP3 receptor-mediated Ca(2&#x2b;) release in mouse B cells results in abnormal B cell development and function</article-title>. <source>J. Immunol.</source> <volume>199</volume> (<issue>2</issue>), <fpage>570</fpage>&#x2013;<lpage>580</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1700109</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thiel</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rossler</surname>
<given-names>O. G.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Ca(2&#x2b;) microdomains, calcineurin and the regulation of gene transcription</article-title>. <source>Cells</source> <volume>10</volume> (<issue>4</issue>), <fpage>875</fpage>. <pub-id pub-id-type="doi">10.3390/cells10040875</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thillaiappan</surname>
<given-names>N. B.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>H. A.</given-names>
</name>
<name>
<surname>Atakpa-Adaji</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>C. W.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>KRAP tethers IP(3) receptors to actin and licenses them to evoke cytosolic Ca(2&#x2b;) signals</article-title>. <source>Nat. Commun.</source> <volume>12</volume> (<issue>1</issue>), <fpage>4514</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-021-24739-9</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsao</surname>
<given-names>H. W.</given-names>
</name>
<name>
<surname>Tai</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H. H.</given-names>
</name>
<name>
<surname>Grenningloh</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Miaw</surname>
<given-names>S. C.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Ets-1 facilitates nuclear entry of NFAT proteins and their recruitment to the IL-2 promoter</article-title>. <source>Proc. Natl. Acad. Sci. U S A.</source> <volume>110</volume> (<issue>39</issue>), <fpage>15776</fpage>&#x2013;<lpage>15781</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1304343110</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaeth</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Feske</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>NFAT control of immune function: new Frontiers for an abiding trooper</article-title>. <source>F1000Res</source> <volume>7</volume>, <fpage>260</fpage>. <pub-id pub-id-type="doi">10.12688/f1000research.13426.1</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vorontsova</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Lock</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>KRAP is required for diffuse and punctate IP(3)-mediated Ca(2&#x2b;) liberation and determines the number of functional IP(3)R channels within clusters</article-title>. <source>Cell. Calcium</source> <volume>107</volume>, <fpage>102638</fpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2022.102638</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>IP3R-mediated Ca2&#x2b; signals govern hematopoietic and cardiac divergence of Flk1&#x2b; cells via the calcineurin-NFATc3-Etv2 pathway</article-title>. <source>J. Mol. Cell. Biol.</source> <volume>9</volume> (<issue>4</issue>), <fpage>274</fpage>&#x2013;<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1093/jmcb/mjx014</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Phan</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>The roles of IP3 receptor in energy metabolic pathways and reactive oxygen species homeostasis revealed by metabolomic and biochemical studies</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1853</volume> (<issue>11 Pt A</issue>), <fpage>2937</fpage>&#x2013;<lpage>2944</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2015.07.020</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>West</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W. G.</given-names>
</name>
<name>
<surname>Dalva</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Dolmetsch</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Kornhauser</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Shaywitz</surname>
<given-names>A. J.</given-names>
</name>
<etal/>
</person-group> (<year>2001</year>). <article-title>Calcium regulation of neuronal gene expression</article-title>. <source>Proc. Natl. Acad. Sci. U S A.</source> <volume>98</volume> (<issue>20</issue>), <fpage>11024</fpage>&#x2013;<lpage>11031</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.191352298</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Yeh</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Parekh</surname>
<given-names>A. B.</given-names>
</name>
</person-group> (<year>2018</year>). &#x201c;<article-title>CRAC channels and Ca(2&#x2b;)-dependent gene expression</article-title>,&#x201d; in <source>Calcium entry channels in non-excitable cells</source>. Editors <person-group person-group-type="editor">
<name>
<surname>Kozak</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Putney</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<publisher-loc>Boca Raton (FL)</publisher-loc>), <fpage>93</fpage>&#x2013;<lpage>106</lpage>.</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoast</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Emrich</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Fike</surname>
<given-names>A. J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>The native ORAI channel trio underlies the diversity of Ca(2&#x2b;) signaling events</article-title>. <source>Nat. Commun.</source> <volume>11</volume> (<issue>1</issue>), <fpage>2444</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-16232-6</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Schug</surname>
<given-names>Z. T.</given-names>
</name>
<name>
<surname>Booth</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Yule</surname>
<given-names>D. I.</given-names>
</name>
<name>
<surname>Mikoshiba</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hajnomicronczky</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Metabolic adaptation to the chronic loss of Ca(2&#x2b;) signaling induced by KO of IP(3) receptors or the mitochondrial Ca(2&#x2b;) uniporter</article-title>. <source>J. Biol. Chem.</source> <volume>298</volume> (<issue>1</issue>), <fpage>101436</fpage>. <pub-id pub-id-type="doi">10.1016/j.jbc.2021.101436</pub-id>
</citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yue</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hamada</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Type 3 inositol 1,4,5-trisphosphate receptor is a crucial regulator of calcium dynamics mediated by endoplasmic reticulum in HEK cells</article-title>. <source>Cells</source> <volume>9</volume>, <fpage>275</fpage>(<issue>2</issue>. <pub-id pub-id-type="doi">10.3390/cells9020275</pub-id>
</citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zagranichnaya</surname>
<given-names>T. K.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Danos</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Villereal</surname>
<given-names>M. L.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Gene expression profiles in HEK-293 cells with low or high store-operated calcium entry: can regulatory as well as regulated genes be identified?</article-title> <source>Physiol. Genomics</source> <volume>21</volume> (<issue>1</issue>), <fpage>14</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1152/physiolgenomics.00099.2004</pub-id>
</citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Takahara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Achiha</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Maki</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Nanoluciferase reporter gene system directed by tandemly repeated pseudo-palindromic NFAT-response elements facilitates analysis of biological endpoint effects of cellular Ca(2&#x2b;) mobilization</article-title>. <source>Int. J. Mol. Sci.</source> <volume>19</volume> (<issue>2</issue>), <fpage>605</fpage>. <pub-id pub-id-type="doi">10.3390/ijms19020605</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>